Wayne State University
Wayne State University Dissertations

1-1-2010

Investigating The Metal Binding Sites In Znta, A
Zinc Transporting Atpase
Sandhya Muralidharan
Wayne State University

Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations
Part of the Biophysics Commons, and the Molecular Biology Commons
Recommended Citation
Muralidharan, Sandhya, "Investigating The Metal Binding Sites In Znta, A Zinc Transporting Atpase" (2010). Wayne State University
Dissertations. Paper 110.

This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in
Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState.

INVESTIGATING THE METAL BINDING SITES IN ZNTA,
A ZINC TRANSPORTING ATPASE
by
SANDHYA MURALIDHARAN
DISSERTATION
Submitted to the Graduate School
of Wayne State University,
Detroit, Michigan
In partial fulfillment of the requirements
for the degree of
DOCTOR OF PHILOSOPHY
2010
MAJOR: BIOCHEMISTRY AND
MOLECULAR BIOLOGY
Approved by:

Advisor

Date

DEDICATION

To my Amma and Achan

ii

ACKNOWLEDGEMENTS
The work presented in this dissertation is the result of several years of learning
and the support and encouragement of several people. The years I spent at Wayne
State University working through this dissertation have been a wonderful experience.
First and foremost, I would like to thank, my parents Indira and Muralidharan and my
sister Smitha for their endless love, motivation, support in every decision I have made
and for believing me in all my dreams. I would also like to thank all my teachers who
have taught me through school and college, and channel my thirst for knowledge.
A very special thank you to my grandmothers, my paternal grandmother whom I
lost during my PhD, for all the love, and affection and my late maternal grandmother for
constantly encouraging and motivating me towards higher education.
I would like to thank my advisor, Dr Bharati Mitra who supported, and
encouraged me throughout this work, for the freedom to pursue my ideas. The work
presented in this thesis would not have been possible without her guidance.
I would like to thank, Dr. David Evans, Dr Timothy Stemmler and Dr Larry
Matherly for their direction as committee members, their comments and suggestions
have contributed vastly to this dissertation. Thanks also to the Department of
Biochemistry and Molecular Biology and Wayne State University School of Medicine for
all the facilities and financial support. I would also like to thank Dr Barry Rosen for
expressing interest in my work. Special thanks to Dr Marilynn Doscher for continued
support and advice as the graduate student advisor. A very big thank you to Mr. Joe
Fiore, Ms. Roselle Cooper, Ms. Yanna Marsh and Ms. Judy Thomas for all the

iii

administrative help and making the life of an international graduate student very
comfortable.
To my lab mates both past and present, the support and encouragement that I
received from them has been enormous. I would like to thank Aster Dewanti and Junbo
Liu, for helping me during my early days in the lab and teaching me skills of membrane
protein purification and molecular biology. Shyamalee Kandegedara is a great friend
and colleague, she is one of the most intelligent, unassuming and humble persons I
have met. I will miss her company, the long scientific and philosophical conversations
with her I will always remember. Thanks to Dhaval Joshi and Iryna King for all the help. I
would also like to thank Suranjana Haldar for all the help with the EXAFS data analysis.
I was lucky to have an opportunity to mentor several undergraduate students, my
interactions with them helped sharpen my teaching skills. Suzan Hadwan and Brian
Rutledge are two undergraduate students I will always remember. It was a joy to teach
them, and I wish them all the very best in their future pursuits.
Very special thanks to all my friends who made my life in Detroit enjoyable and
fun-filled. Smriti Anand, my former roommate for being a very good friend and a sisterly
figure. Madhura Chakrabarti who has supported me in so many ways, for being there in
good and bad, for all the crazy movies, endless hours of shopping and yapping, I wish
her all the very best in the pursuit of her PhD degree. I am also very grateful to
Shreyashi Ganguly, Jayprakash Saha, for being such good friends and Shreyashi,
especially for providing loads of laughter at the end of a tiring day.
At the Department of Biochemistry, I have had the opportunity to meet people of
different nationalities; some of them over the years have become very close friends. I

iv

would like to thank Kristina Bencze for being a great friend and helping me during the
initial days in graduate school. Ying, Poorna Subramanian, Andrea Rodrigues, Ana
Jankovic, Song Chen, Jianbo Yang, Masafumi Yoshinaga, Jeremy Cook, Asmita
Vaishnav and Elizabeth Masko for all the joyful times, late nights in the department and
endless discussions about experiments.
I would also like to thank all my friends and family outside Detroit for their
constant support, with a special thanks to Dr.Shridhar and Mrs.Nirmala Bhat,
Mr.V.C.Pisharody

and

Mrs.Rajalakshmi

Pisharody,

Ms.Vasumathi

Bharathan,

Mr.T.P.Narayanan and Mrs.Vijayalaskshmi Narayanan, Mr. Val Narayanan and
Mrs.Latha Narayanan, Mr.Sankaranarayanan and Mrs.Kamala Sankaranarayanan,
Mr.Gopalakrishnan and Mrs.Devaki Gopalakrishnan, Mr.Sreejith Ramachandran,
Dr.Kavitha Chendil Kumar, Dr.Pankhuree Verma, Ms.Shilpa Ramanujam and Mr.Dinesh
Rabindran.
And finally, to my husband, Santosh Pisharody for the unconditional love,
patience and optimism, to continue with my degree. I do not have enough words to
express my thanks, for all the support and confidence he has provided.

v

TABLE OF CONTENTS
Dedication . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ii
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .iii
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .xiv
List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .xv
Chapter 1:

An Introduction to Transition Metal Homeostasis. . . . . . . . . . . . . . . . . .1

1.1

Inorganic Physiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

1.2

Cellular Metal Homeostasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

1.2.1

Metallochaperones. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

1.2.2

Metal Sensors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

1.2.3

Metal Sequestering Proteins. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5

1.2.4

Transcriptional and Translational metal regulation. . . . . . . . . . . . . . . . . .6

1.2.5

Post translational metal regulation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

1.2.6

Metal transporters. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7

1.2.7

Examples of how these metalloproteins regulate copper and
iron homeostasis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8

1.3

Chemistry of Transition Metals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9

1.3.1

Irving-William Series. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9

1.3.2

Chemical Properties of Metals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10

vi

1.4

Background on Zinc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

1.4.1

Chemistry of Zinc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

1.4.2

Biology of Zinc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

1.5

Transport systems for zinc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14

1.6

Zinc homeostasis in E.coli. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

1.7

P-type ATPases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..19

1.8

Classification of P-type ATPases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

1.9

Classification of PIB ATPases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25

1.10

Background on ZntA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28

1.11

Lead and Cadmium. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36

1.12

Aims of the thesis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .36

1.13

Significance of the thesis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .39

1.14

References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40

Chapter 2:

Conserved motifs in the amino terminal domain of ZntA: their role in
metal binding and selectivity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50

2.1

Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50

2.2

Materials. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53

2.3

Experimental Methods. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53

vii

2.3.1

Construction N1-ZntA with carboxyl - terminal strep tag. . . . . . . . . . . ..53

2.3.2

Construction of C29A, C30A, C31A, D32A, D32N, C35A,
D58A, D58N, C59A, C62A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53

2.3.3

Protein expression and Purification of the ZntA mutants. . . . . . . . . . . 55

2.3.4

Protein expression and purification of N1-ZntA and
N1-ZntA mutants. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .57

2.3.5

Determination of Protein Concentration. . . . . . . . . . . . . . . . . . . . . . . . . 58

2.3.6

ATPase Activity Measurements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58

2.3.7

Measurement of Metal Binding Affinity of the N1-ZntA mutants. . . . . . 59

2.3.8

Preparation of Metal bound N1 and N1-mutants. . . . . . . . . . . . . . . . . . 59

2.3.9

Measurement of Metal Binding Stoichiometry of the N1-ZntA
mutants by ICP-MS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60

2.3.10

Sensitivity to metal salts. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60

2.3.11

X-Ray Absorption Spectroscopy (XAS) . . . . . . . . . . . . . . . . . . . . . . . . .60

2.4

Results. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63

2.4.1

The in vivo resistance activity of N1-ZntA mutants to
Pb+, Zn2+ and Cd2+ in the growth medium. . . . . . . . . . . . . . . . . . . . . . . 63

2.4.2

Activity of the Purified N1-ZntA mutants. . . . . . . . . . . . . . . . . . . . . . . . .66

2.4.3

Stoichiometry of Metal Binding to N1-ZntA mutants

viii

using ICP-MS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
2.4.4

Affinity of Pb2+, Zn2+ and Cd2+ for the amino terminal metal binding
site mutants using direct fluorescence quenching. . . . . . . . . . . . . . . . . 71

2.4.5

Analysis of Lead, Zinc, Cadmium, Cobalt and Copper
binding by X-ray absorption spectroscopy. . . . . . . . . . . . . . . . . . . . . . . 75

2.5

Discussion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86

2.6

References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .91

Chapter 3:

The N-terminal domain of ZntA: it’s role as a chaperone to the
transporter. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95

3.1

Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .95

3.2

Materials. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .98

3.3

Methods. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

3.3.1

Construction of ZntA and ∆N with a carboxyl–terminal strep tag. . . . . . 99

3.3.2

Construction N1-ZntA with carboxyl - terminal strep tag. . . . . . . . . . . 99

3.3.3

Construction of Co-expression vector containing both ∆N–ZntA
(Membrane domain) and N1–ZntA (N-terminal domain) in
pBADmycHisP. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .100

3.3.4

Construction of double and single cysteine mutants in ∆46-ZntA. . . . 101

3.3.5

Expression and purification of N terminal domain of ZntA (N1-ZntA) . 103

ix

3.3.6

Expression and Purification of ZntA and ∆N- ZntA. .. . . . . . . . . . . . . . .104

3.3.7

Protein concentration determination. . . . . . . . . . . . . . . . . . . . . . . . . . .105

3.3.8

Metal bound sample preparation for ATPase activity
measurements and Transport Assay. . . . . . . . . . . . . . . . . . . . . . . . . . 105

3.3.9

Measurement of Metal Concentration by ICP-MS. . . . . . . . . . . . . . . .106

3.3.10

ATPase activity assay. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106

3.3.11

Transport Assays in everted membrane vesicles. . . . . . . . . . . . . . . . .107

3.3.12

Fluorescence Studies to monitor intermolecular crosslinking. . . . . . . .108

3.3.13

Fluorescence studies to monitor intramolecular crosslinking. . . . . . . .109

3.3.14

Competition Survival Assay. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109

3.3.15

Sensitivity to metal salts. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .110

3.4

Results. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110

3.4.1

N1-ZntA confers a Competitive Advantage to ZntA. . . . . . . . . . . . . . . 110

3.4.2

The resistance profile of co-expression vector in the presence
of Pb2+, Cd2+, and Zn2+ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112

3.4.3

ZntA and ∆N membrane vesicles supplied with N1-bound
metal as the substrate catalyze ATP- dependent transport
of lead, zinc and cadmium. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .115

3.4.4

Metal bound N-terminal domain activates the transmembrane

x

domain of ZntA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
3.4.5

Interaction of N1 with ∆N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121

3.4.6

Proximity of the two metal binding domains. . . . . . . . . . . . . . . . . . . . . 123

3.5

Discussion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .125

3.6

References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129

Chapter 4:

Characterizing the metal binding properties of a truncated form
of ZnTa that is structurally similar to the pineal night-specific
ATPase encoded by the Wilson Disease Gene . . . . . . . . . . . . . . . . . . 133

4.1

Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .133

4.2

Materials. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .137

4.3

Methods. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..138

4.3.1

Construction of Del231-ZntA with a carboxyl-terminal His tag
and carboxyl terminal strep tag. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138

4.3.2

Protein expression of Del231-ZntA. . . . . . . . . . . . . . . . . . . . . . . . . . . . 138

4.3.3

Protein Purification of Del231-ZntA. . . . . . . . . . . . . . . . . . . . . . . . . . . .139

4.3.4

Determination of Protein Concentration. . . . . . . . . . . . . . . . . . . . . . . . 140

4.3.5

Sensitivity to metal salts. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141

4.3.6

ATPase Activity Measurements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141

xi

4.3.7

Preparation of Metal bound Del231-ZntA. . . . . . . . . . . . . . . . . . . . . . .142

4.3.8

Measurement of Metal Binding Stoichiometry of Del231-ZntA
by ICP-MS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142

4.4

Results. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143

4.4.1

The in vivo resistance activity of Del231-ZntA mutant to Pb2+,
Zn2+ and Cd2+ in the growth medium. . . . . . . . . . . . . . . . . . . . . . . . . ..143

4.4.2

Activity of the purified Del231-ZntA. . . . . . . . . . . . . . . . . . . . . . . . . . ..145

4.4.3

Stoichiometry of Metal Binding to Del231-ZntA using ICP-MS. . . . . . .147

4.5

Discussion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147

4.6

References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .149

Chapter 5: Conclusions and Future Directions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
Autobiographical Statement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

xii

157

LIST OF TABLES
Table 1.1.

The Composition of some common elements in the human body. . . . . . . 1

Table 1.2

Chemical Properties of Transition Metals. . . . . . . . . . . . . . . . . . . . . . . . . 11

Table 1.3

Chemical Properties of some Non Essential Metals. . . . . . . . . . . . . . . . . 12

Table 1.4

Hard-Soft Acid Base Classification of Metal ions and Ligands . . . . . . . . . 35

Table 2.1

Kinetic parameters for N1-mutants in the presence of lead. . . . . . . . . . . . 67

Table 2.2

Kinetic parameters for N1-mutants in the presence of zinc . . . . . . . . . . . 68

Table 2.3

Kinetic parameters for N1-mutants in the
presence of cadmium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69

Table 2.4

Metal binding stoichiometry of N1-mutants. . . . . . . . . . . . . . . . . . . . . . . . .71

Table 2.5

Association Constants for binding of Lead, Zinc and Cadmium to
mutants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75

Table 2.6

EXAFS Fitting results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85

Table 3.1

Kinetic parameters for ∆N and ZntA . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118

Table 4.1

Kinetic parameters obtained for ZntA and Del231-ZntA. . . . . . . . . . . . . 146

Table 4.2.

Metal binding stoichiometry of Del231-ZntA . . . . . . . . . . . . . . . . . . . . . . 147

xiii

LIST OF FIGURES
Figure 1.1.

Zinc Homeostasis in E.coli. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19

Figure 1.2.

The Post-Albers Cycle based on the Na+/K+ ATPase. . . . . . . . . . . . . . 21

Figure 1.3.

Calcium ATPase Structure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22

Figure 1.4.

Classification of PIB-2 ATPases. . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . .28

Figure 1.5.

Schematic representation of ZntA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .29

Figure 1.6.

Sequence Alignment of N-terminal domain of PIB-2 subgroup. . . . . . . . . .30

Figure 1.7.

Solution structures of N-terminal domain of CadA, ZntA and CopA. . . 32

Figure 1.8

Sequence alignment of Helix 6 of ZntA and its close homologues. . . . . .33

Figure 1.9.

Sequence alignment of Helix 7 and 8 of ZntA and its close
Homologues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..33

Figure 1.10 Sequence Alignment of Helix8 of ZntA compared to Helix 6 of
Ca2+ ATPase and Na+/K+ ATPase. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Figure 2.1.

Sequence Alignment of N-terminal domain of PIB-2 subgroup. . . . . . . . . .52

Figure 2.2

Resistance profile of the N-ZntA mutants to lead, zinc and cadmium.. . . 64

Figure 2.3.

Fluorescence Spectra obtained for titration of N1-ZntA with Lead. . . . . . 73

Figure 2.4

Plot of change in fluorescence emission. . . . . . . . . . . . . . . . . . . . . . . . . .74

Figure 2.5.

EXAFS and Fourier transforms of lead bound N1-ZntA. . . . . . . . . . . . ... 76

Figure 2.6

EXAFS and Fourier transforms of zinc bound N1-ZntA. . . . . . . . . . . . . ..78

xiv

Figure 2.7

EXAFS and Fourier transforms of copper bound N1-ZntA. . . . . . . . . . . . 80

Figure 2.8

EXAFS and Fourier transforms of cobalt bound N1-ZntA. . . . . . . . . . . . .81

Figure 2.9

EXAFS and Fourier transforms of cadmium bound N1-ZntA. . . . . . . . . . 83

Figure 2.10 Sequence alignments of the N-terminal domain of PIB ATPases. . . . . . . 90
Figure 3.1.

Metal Binding sites in ZntA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97

Figure 3.2

Scheme for construction of co-expression vector. . . . . . . . . . . . . . . . . .101

Figure 3.3

Location of restriction sites in the position of cysteine residues. . . . . . . 103

Figure 3.4

Model for Transport Assay in everted membrane vesicles. . . . . . . . . . .108

Figure 3.5

Agarose gel picture of Molecular competition assay. . . . . . . . . . . . . . . .112

Figure 3.6

Resistance profile of co-expression vector. . . . . . . . . . . . . . . . . . . . . . .114

Figure 3.7

Plots of the Transport Assay. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116

Figure 3.8

Representative ATPase activity assay plots obtained for ∆N. . . . . . . . .119

Figure 3.9

Representative ATPase activity assay plots obtained for ZntA. . . . . . . .120

Figure 3.10 Fluorescence resonance energy transfer spectra. . . . . . . . . . . . . . . . . .122
Figure 3.11 Model showing cysteine residues in ∆46-ZntA. . . . . . . . . . . . . . . . . . . ..123
Figure 3.12 Fluorescence emission spectra showing the pyrene excimer. . . . . . . . .125
Figure 3.13 Model for metal delivery to the transmembrane metal binding site
in ZntA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129

xv

Figure 4.1

Membrane topology of PIB and P2/P3 ATPases. . . . . . . . . . . . . . . . . . 133

Figure 4.2

Structure of PINA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..137

Figure 4.3

Structure representing ZntA and Del231-ZntA. . . . . . . . . . . . . . . . . . . . 137

Figure 4.4

Resistance profile of Del231-ZntA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143

xvi

1
CHAPTER 1
AN INTRODUCTION TO TRANSITION METAL HOMEOSTASIS
All living organisms are maintained by constant chemical processes which
require many of the elements of the periodic table. Metals play different roles in
living systems (1). Organisms have evolved to make use of the special properties
of metals to perform many important functions. Some of these are for biological
signaling processes, charge maintenance, structural roles, electron transfer,
enzyme catalysis, dioxygen transport (2-3). The metal ions are made available to
the organisms by various methods depending upon the surrounding conditions;
these elements can be made bioavailable or the organisms accumulate the
necessary nutrients by several processes.
Table 1.1. The Composition of some common elements in the human body(2).
ELEMENT

PERCENTAGE(by weight)

Sodium, Potassium, Sulfur

0.1

Chlorine

0.09

Silicon, Magnesium

0.04

Iron, Fluorine

0.005

Zinc

0.003

Copper, Bromine

2 X 10

Selenium, Manganese, Arsenic, Nickel

2 X 10

Lead, Cobalt

9 X 10

-4

-5

-6
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1.1 INORGANIC PHYSIOLOGY
Living cells constantly acquire, store and transport metal ions such that
the

optimal

concentrations

of

these

metals

are

readily available

for

metalloproteins and also to protect themselves from the toxic effects of metal
excess (3). The optimal concentrations of different metals can vary widely. The
concentration of calcium is very high in the human body and its major use is the
stabilization of the endoskeleton (2). Also are present large amounts of
potassium, sodium and magnesium which function to maintain charge and
osmotic balance or as structural elements (2). These elements belong to Groups
I and II of the periodic table and are called macro nutrients (2, 4). Some
elements like iron, zinc, copper, molybdenum, cobalt, chromium, vanadium and
nickel are less abundant. These transition metals are called trace metals (2).
Iron, copper, zinc, cobalt, and nickel are essential for organisms and play several
important biological roles. Iron is involved in dioxygen transport in hemoglobin
and myoglobin and in electron transfer (2, 4) . Copper serves as an electron
carrier in cytochrome c oxidase, as a facilitator of oxygen transport in
hemocyanin, and also as a catalytic site for enzymes such as superoxide
dismutase (2, 4). Zinc functions as a structural element in zinc finger proteins; it
plays a regulatory role (in superoxide dismutase) and catalytic roles in several
enzymes. Cobalt serves in alkyl group transfer in Vitamin B12 and oxidases (2).
Nickel is involved in nitrogen fixation, oxo transfer in oxidases, and plays a
catalytic role in hydrogenases and hydrolases (2, 4).
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Studies in bacterial cells have shown that they maintain transition metal
ions in a fixed and narrow range; this is represented as the total number of metal
atoms per cell, and this value is called the metal quota (5). E.coli, for instance
concentrates transition metal ions down to a narrow range as follows: iron and
zinc (~0.1mM), and copper, manganese, molybdenum and selenium (~ 0.01mM)
(6). Other metal ions such as sodium, potassium and magnesium are highly
abundant in bacterial cells (~10mM) (6). Some toxic metals like cadmium,
mercury, lead are also found in organisms but do not have any specific or known
biological role. For this reason, metal ion concentrations have to be very tightly
controlled since they are essential for survival but at the same time any change
in concentration can cause havoc. Essential transition metal levels in a cell have
to be precisely regulated such that there is a sufficient supply of the metal, at the
same time an excess of essential and the non essential metals must be avoided
since it would lead to metal toxicity. This process of maintaining the
concentration of essential metal ions in the right concentration range is called
homeostasis, and detoxification or resistance is the removal of toxic
concentrations of non essential metal ions (7). All organisms have to maintain
metal homeostasis for survival.
1.2 Cellular Metal Homeostasis
Metal ion regulation is a very important cellular function performed in
unison by several proteins: metallochaperones, metalloregulators and metal
transporters (8). These proteins are involved in the tightly regulated processes of
uptake, storage and secretion. Two decades ago, the discovery of the genes
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responsible for Wilsons, Menkes, and Lou Gehrig’s diseases threw light on
cellular metal homeostasis mechanisms (9). Wilsons disease is an autosomal
recessive disorder characterized by the accumulation of toxic amounts of copper
in the liver, kidney and brain (10). ATP7B, a 1411 – amino acid copper
transporting ATPase, is the gene responsible for this disease; it is located on
chromosome 13 (10). Menkes disease is an X-linked disorder characterized by a
deficiency of copper and is caused by defects in the ATP7A gene (11). Both
these proteins are involved in copper transport. Some other proteins which were
subsequently studied were transferrin that transports iron into the cell, its
counterpart being ferritin which is involved in iron efflux (11). Studies on the
Wilsons and Menkes proteins and similar proteins in several organisms have
lead to models showing how chaperones, sensors and transporters work towards
metal delivery, and positioning metals in the required location in the cell.
1.2.1 Metallochaperones
Metallochaperones are helper proteins which bind to metal ions and
transfer them to the target proteins (12).Copper, nickel and iron chaperones are
well documented. Examples of chaperone proteins are Atx1 which is the first
copper chaperone to have been identified in S.cerevisiae; the human homolog of
this protein is Atox1 which transfers copper to the Menkes and Wilsons disease
proteins (9).The bacterial homolog of Atox1 and Atx1 is CopZ in E.coli which
interacts with CopA and CopY (9, 12). CCS is a copper chaperone for
superoxide dismutase which inserts copper directly into the target protein (12).
So far only two known iron chaperones have been documented in literature.
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Frataxin, a protein implicated in a neurological disease Friedreich’s ataxia, is a
mitochondrial iron chaperone (13). Human poly(rc) binding protein 1 (PCPB1) is
a cytosolic iron chaperone that binds to iron and loads ferritin (13). The nickel
chaperone UreE delivers the metal to the active site of the enzyme Urease (14).
Chaperone proteins for very few metals are known, so it is thought that most
proteins get their metals from the cytoplasmic metal pools. But then, how do the
cells sense the need for metal ions?
1.2.2 Metal Sensors
Metal sensors are transcriptional regulators; they detect and respond to
metal deficiency or excess in the cells. There are several bacterial sensors which
have been identified they are classified as metal de-repressors, co-repressors
and metal activators (15). ArsR-SmtB, CsoR-RcnR and CopY are some of the
metal de-repressors and Fur, NikR and DtxR are co-repressors, and MerR is an
example of an activator (15).
1.2.3 Metal Sequestering Proteins
Cells can control the transport of metal ions but at the same time they can
also control the free metal ion concentrations with the help of metal sequestering
proteins. The example of Metallothionein illustrates the role of a metal
sequestering protein. It participates in the process of sequestering metals such
as zinc and thus serves as a reservoir for zinc ions (16). In addition to zinc,
metallothionein can also bind to cadmium, and lead. Metallothionein is a cysteine
rich protein that can bind to seven zinc ions in two zinc/thiolate clusters. In one
cluster, three zinc ions are bound to nine cysteines (Zn3S9) and the other has
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four zinc bound to eleven cysteines (Zn4S11) (16). In these clusters, zinc is in a
tetrahedral coordination environment with the sulfurs (16). The different zinc ions
bind to metallothionein with a range of affinities. Cadmium also binds to
metallothionein with four coordinate geometry. Unlike zinc and cadmium,
metallothionein binds to lead in trigonal geometry (17).
1.2.4 Transcriptional and Translational metal regulation
Metal regulatory transcription factor (MTF1) genes are induced in
response to metals such as copper, cadmium and zinc. Studies have reported
that zinc stabilizes a complex between MTF1 and its DNA binding site (15). The
Drosophila MTF1 has a copper cluster and zinc fingers, the cysteine residues
that coordinate the cluster when replaced by alanine do not upregulate the
transcription of copper metallothionein gene in response to a high concentration
of copper (15). Also are present several proteins that control translation or
mRNA stability for different gene products. Some examples are the iron
responsive proteins IRP1 and IRP2; they bind to iron responsive elements in
mRNAs that encode ferritin and transferring receptor. Ferritin is required when
there is excess iron and transferrin is needed when there is low amount of iron
(15).
1.2.5 Post translational metal regulation
Degradation of proteins involved in metal homeostasis is a way of post
translational metal regulation; this applies to several proteins such as the iron
responsive protein IRP2, the copper chaperone CCS, the copper importer CTR1,
the iron efflux protein ferroportin and the zinc uptake transporter ZIP4 (15). ZIP4
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is a good example to explain the phenomenon of post translational metal
regulation. When zinc is low, the extracellular amino terminal domain of ZIP4
undergoes proteolytical degradation (15). When zinc is absent ZIP4 is removed
from the plasma membrane to a perinuclear location and when zinc is very high
ZIP4 is degraded. ZIP4 has a histidine rich motif that is responsible for
ubiquitination and proteolytic degradation (15). This motif also responds to
cadmium by triggering degradation.
1.2.6 Metal transporters
Metal transporters are important members of the metal trafficking
machinery. The uptake and efflux transporters are expressed under decreased
and high metal conditions, respectively. Some of the transporters at the
cytoplasmic membrane are ABC (ATP-binding cassette)-type ATPases, P-type
ATPases, cation diffusion facilitator proteins, NRAMPs (natural resistance
associated with macrophage protein) and ZIPs (Zrt /Irt – like protein) (18). The
ABC transporters and the P-type ATPases utilize the energy from ATP hydrolysis
to pump metal ions. ABC transporters are uptake pumps, they import
manganese, zinc, nickel and iron across the cell membrane (18). These pumps
work in unison with proteins located in the periplasm. P-type ATPases are efflux
pumps that export a wide variety of metals. The CDF proteins export ions from
the cytoplasm, through a coupled transport of two ions in the opposite direction
(18). Nramp is a large family of proton coupled transporters that have roles in
uptake of iron and manganese (18). Mammalian members of the ZIP family of
proteins have been identified.
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Thus, metallochaperones, metal sensing proteins and metal transporters
together play an important role in regulating the intracellular transition metal
concentration and helping cell survival.
1.2.7 Examples of how these metalloproteins regulate copper and iron
homeostasis
Copper homeostasis
In mammals, copper is absorbed from the gastrointestinal tract by a Ptype copper transporting ATPase, ATP7A (Menkes protein) (19). Cu+ is then
transported into the cell by the human copper transporter(hCTR1), and from here
is further delivered to other targets by other copper chaperone proteins like
Atox1, Ccs1, Cox17 and glutathione for delivery to Wilsons protein (ATP7B),
superoxide dismutase, cytochrome oxidase, and metallothionein (19-20). ATP7B
then transports copper to the luminal side of the secretory network (19).
Iron homeostasis
Like copper, iron is another vital metal that is required for the formation of
hemoglobin and myoglobin; it helps maintain a healthy immune system (21). The
iron homeostasis machinery mainly involves transferrin, iron that is absorbed is
bound to transferrin (22). Transferrin receptors assist transferrin in shuttling the
iron to cellular targets. Some other proteins involved in iron homeostasis are
DMT1(divalent metal transporter1), ferroportin, ceruloplasmin, Nramp2 (21-22).
Unlike the copper and iron metabolism and homeostasis, which have
been well studied and documented, very little is known about the uptake and
storage of other metal ions. In the pursuit of understanding the details of other
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metal homeostasis, our lab over the years has worked on metal transporters and
my research over the past few years has focused on a zinc efflux pump in E.coli
– the zinc transporting ATPase, ZntA.
1.3 Chemistry of Transition Metals
Transition metal ions in cells are found chelated to proteins or cofactors;
the common metal ligands are O, N, S, or C. Within the cell there are present a
large number of non specific binding sites for metals, thus it is truly a challenge
to accommodate each metalloprotein with the correct metal ion (14). How does
nature distinguish between the different transition metal ions and maintain a
balance of ions? In order to understand this phenomenon one must first be
familiar with the Irving-William series (the natural order of stability for divalent
transition metals) and also the chemical properties of transition metals.
1.3.1 Irving-William series
In the complex cellular environment, as per the Irving-William series
copper and zinc form the tightest complexes, then nickel and cobalt, then ferrous
iron and manganese and finally the weakest complexes are formed by calcium
and magnesium (Mg2+< Ca2+ <Mn2+ <Fe2+ <Co2+ <Ni2+ <Cu2+ >Zn2+) (14) . But
within the same cell some proteins bind to uncompetitive metals and some
proteins bind to competitive metal ions. How do the proteins distinguish the
wrong metals from the right ones? Cells overcome the problem imposed by the
Irving-William

series

by

compartmentalization

and

this

was

recently

demonstrated by two periplasmic proteins in cyanobacteria, MncA for
manganese and CucA for copper (23). Manganese and copper are at the
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opposite ends of the Irving-William series, and both proteins prefer to bind to
copper in vitro. The concentration of manganese in the cytoplasm is ~10 µM and
that of copper is in the pM range (4). The MncA protein is a substrate for Tat
(twin-arginine translocase) which helps MncA to fold in the cytoplasm to trap
manganese; now MncA is folded and the metal binding site is buried inside the
protein (23). On the other hand CucA is a substrate for Sec (general secretory
pathway) which enables the CucA to fold in the periplasm after export thus
binding to the competitive copper (23). Thus MncA and CucA can exist together
and manganese cannot be replaced by the competitive copper.
1.3.2 Chemical Properties of Metals
Transition metals are involved with many different metalloproteins. Most of these
transition metals have more than one oxidation state. Some oxidation states are
more common than the others. They also display different geometry and
coordination which may govern metal selectivity and specificity.
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Table 1.2. Chemical Properties of Transition Metals (2).
Oxidation State

Coordination

Geometry

Number
Iron(II), d6

4-6

Tetrahedral, Octahedral

Iron(III),d5

3-8

Trigonal, Tetrahedral, Square planar,
Trigonal bipyramidal, Octahedral

Cobalt(I),d8

6

Octahedral

Cobalt(II),d7

4,6

Tetrahedral, Octahedral

Cobalt(III),(d6)

6

Octahedral

Nickel(II),d8

4,6

Square planar, Octahedral

Copper(I), d10

3,4

Trigonal planar, Tetrahedral

Cu(II),d9

3-6

Trigonal planar, Tetrahedral, Square
pyramid, Tetragonal, Square planar

Zinc(II),d10

4-6

Tetrahedral, Square pyramid,
Octahedral

Knowledge of the chemical properties of non essential metal ions like cadmium,
lead and mercury is very useful in understanding how these metals mimic
essential metal ions leading to toxic side effects.
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Table 1.3. Chemical Properties of some Non Essential Metals (2).
Oxidation State

Coordination

Geometry

Number
Cadmium(II), d10

4,6

Tetrahedral, Octahedral

Lead(II),d10

3-6

Trigonal, Pyramidal, Square planar,
Octahedral

Mercury(II),d10

2

Linear

1.4 Background on Zinc
Zinc is the most common transition metal ion in the cytoplasm, but it is not
as prevalent as group 1 and 2 metal ions (4). Zinc, which is essential for cell
survival, serves as a cofactor for many enzymes. It plays a structural role as a
scaffold for RNA polymerase, and tRNA synthetases (24). Zinc inhibits free
radical formation and thus protects sulfhydryl groups. When the cellular
concentration of zinc increases it has toxic effects; it blocks thiols and prevents
disulfide bond formation and binding of other metals to their active sites (18, 2425).
1.4.1 Chemistry of Zinc
Zinc has an outer electronic configuration of 3d104s2. Zinc is a very small
ion (radius 0.65Å) and has a very concentrated charge to size ratio (4). It is also
a good electron acceptor or Lewis acid, and its electron affinity is similar to
copper and nickel (4). These metal ions bind to donors such as thiolates and
amines with a high affinity. However, zinc does differ from copper and nickel in
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its oxidation state (4). Both copper and nickel display multiple oxidation states.
This redox inertness of zinc is perhaps a reason why it is a preferred metal ion in
several biological reactions since redox activity introduces the risk of free radical
formation (4). In addition to small size, high charge density and redox inertness,
it also displays both hard and soft metal character. Zinc uses sulfur, oxygen and
nitrogen as ligands in biological systems (17). Cys, His, Asp, and Glu are the
most common amino acid ligands in zinc proteins. The coordination geometries
preferred by zinc in biology are tetrahedral and trigonal bipyramidal (2). The
diverse properties and flexible nature of zinc may explain why it is the only metal
being represented in all six recognized classes of enzymes (17). The properties
that make zinc valuable in biology relative to other metals are its availability, fast
ligand exchange, redox inertness, flexible coordination geometry, good Lewis
acid properties, and intermediate soft metal character; these are all put to
particular uses in the cell.
1.4.2 Biology of Zinc
Zinc bound to proteins can play both structural and catalytic roles. Two
well known zinc metalloproteins are Cu/Zn superoxide dismutase and alcohol
dehydrogenase (Adh1). These are examples of high affinity zinc sites; low affinity
zinc binding sites are present on proteins, lipids, and DNA and amino acids
(histidine), glutathione and organic anions (citrate) (26). Since zinc is an integral
part of so many proteins and reactions, the amount of free zinc in the cell must
be very low. The term “free” is used to specify the labile zinc that is freely
available for participating in reactions (26). Studies suggest that the total amount
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of zinc present in the cell is in the millimolar range (6, 26). Many of the zinc
metalloproteins have very high binding affinities, 1 nM zinc is equivalent to about
30 zinc ions per yeast cell and about 300 ions in a mammalian cell (26).
Interestingly, free zinc is much lower in concentration (femtomolar range) despite
the total amount of zinc being so much higher (6, 26-27). This underscores the
perfect regulation of free zinc inside the cell and the delicate balance between
zinc uptake, efflux, and sequestration.
Zinc regulators induce or repress specific operons or genes. These gene
products are involved in zinc transport. In E.coli two zinc sensors Zur and ZntR
have affinities in the femtomolar range for zinc which is much lower than the
concentration of zinc in the cell (26-27). When the cell is zinc deficient, the Zur
regulatory protein which is a member of the Fur family of bacterial metal
responsive regulators, induces the expression of uptake transporters such as
ZnuABC and ZupT (17, 26). Once the uptake stops, the accumulated zinc is
used by the zinc proteins or the excess is exported out of the cell. ZntR which
belongs to the MerR family of transcriptional regulators, induces the efflux
transporter ZntA (17).
1.5 Transport systems for zinc
Transporters are a major component of the zinc homeostasis machinery.
The import of zinc and its transport out of the cell requires several membrane
transport proteins. Zinc transport proteins belong to several families: some of
them are ZIP proteins, ABC transporters, RND transporters, P-type ATPases,
and CDF proteins (26, 28).
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The ZIP proteins [(Zrt/Irt-like protein) ZIP (SLC39) family]
The first identified members of this family were the yeast Zrt1 and the
Arabidopsis Irt1 proteins. Mammalian ZIP proteins have been designated as
SLC39 (26, 28). The ZIP proteins have 8 transmembrane domains (29). Many
proteins that belong to this family have a histidine rich loop located between the
3rd and 4th transmembrane domains which maybe involved in zinc binding (29).
The mechanism of transport used by ZIPs is still not very clear. Zrt1 in yeast
uses energy to transport zinc, whereas the human Zip2 (SLC39A2) is not energy
dependent (29). Studies show that zinc uptake by the mammalian transporter
may be due the HCO3 gradient across the cell membrane (26).
The ABC transporter family
This is a diverse group of active membrane transporters. Members of this
group mediate a variety of transport processes in both prokaryotes and
eukaryotes. They play a role in maintaining metal homeostasis by importing
metal ions such as zinc; in addition they are also involved in the uptake of
nutrients, resistance to cytotoxic drugs and antibiotics, and cholesterol and lipid
trafficking (26). ABC transporters are a complex of three proteins, one or two of
them being membrane embedded (30). These proteins form a pore in the
membrane that permits the transport of specific substrates (28). Energy of ATP
hydrolysis is used to transport substrate across the membrane (28).
The CDF proteins
The mammalian members of the cation diffusion facilitator (CDF) family
are called ZnT (SLC30) (26). CDF transporters are present bacteria, fungi, plants
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and mammals. Most members of this family have six transmembrane domains
(26, 28). The CDF proteins also have a histidine rich cytoplasmic loop between
transmembrane domains 4 and 5. Many CDF proteins transport metals by
antiport (Zn2+/H+ or K+) (26).
The RND (Resistance-Nodulation-Division) family
An example of the RND family is the CzcABC protein in Ralstonia
metallidurans. The CzcD protein is induced under high Zn2+ concentrations (31).
CzcA, CzcB and CzcC form a complex system that exports Zn2+, Co2+ and Cd2+
across the cytoplasmic and outer membrane. CzcA is a cation–proton antiporter
that is located in the cytoplasmic membrane (31). CzcB is located in the
periplasm. CzcC connects CzcB to the outer membrane to form CzcABC protein
complex (31).
Other Efflux Transporters
Zinc efflux transporters mediate the export of intracellular zinc to avoid the
over accumulation of zinc and thus protects the cell from toxic side effects of zinc
overload. In mammalian cells, Znt1/SLC30A1 which belongs to the CDF family
plays a role in zinc efflux to maintain cellular zinc homeostasis and transepithelial zinc trafficking (26). In the brain, the zinc efflux transporters are very
important after an ischemia or epileptic seizures as there is high accumulation of
zinc (32). Yeast is different from other eukaryotes; it does not have any zinc
efflux systems but the excess zinc is sequestered into vacuoles and this is a site
for detoxification (26).
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1.6 Zinc homeostasis in E.coli
E.coli is a very good model system to study zinc transporters. Our lab has
for several years used E.coli transporters as model systems to characterize
metal transporters. E.coli has a zinc quota of ~ 105 atoms of zinc per cell (6, 26).
E.coli has both high and low affinity transporters that work together to maintain
cellular zinc homeostasis.
Broad Spectrum Zinc uptake transporter in E.coli
When the zinc concentration in an E.coli cell is within the normal range, a
broad substrate transporter ZupT is induced. ZupT is the first characterized
bacterial uptake pump that belongs to the ZIP family of proteins (33). ZupT has
eight transmembrane helices and studies have shown that ZupT is involved in
the uptake of several ions such as Zn2+,Fe2+,Co2+,Cd2+ and Mn2+(33-34). The
energy source and the mechanism of transport are not clear.
High affinity Zinc uptake pump in E.coli
When zinc concentrations are extremely low, the E.coli operon znuABC is
induced by Zur. The ATP dependent uptake of zinc is catalyzed by ZnuABC.
This pump depends on ZnuA which is a periplasmic binding protein having the
ability to bind metal ions and ATP (18). ZnuB is the membrane permease and
ZnuC is the subunit that catalyses ATP hydrolysis (18).
Low Affinity zinc Efflux transporter in E.coli
Unlike the transporters involved in zinc uptake, the zinc export proteins
have more specific substrates. Here too, there are high affinity and low affinity
systems. ZitB (YbgR) a member of the CDF family is a low affinity zinc efflux
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transporter (18). Sequence analysis and site directed mutagenesis studies
suggest several residues such as His53, His159, Asp163 and Asp186 are
essential for function (18). It has been observed that these residues are
conserved in other CDF proteins even though the metal transported may vary
suggesting that these residues may form a proton channel (17).
High Affinity Zinc Efflux transporter in E.coli
In E.coli, when there is an over accumulation of zinc, ZntR a zinc sensor
activates the expression of an active transporter ZntA (Zinc transporting ATPase)
which is a high affinity pump that is involved in zinc efflux (28). ZntA belongs to
the P-type ATPase family of transporters. These are a class of ion pumps that
are involved in many biological processes such as generating membrane
potential, muscle contraction, removal of toxic ions from cells.

19

Figure 1.1. Zinc Homeostasis in E.coli.
1.7 P-type ATPases
In 1950’s Jens Skou discovered the first P-type pump, the Na+/K+ ATPase
that uses ATP to transport Na+ and K+ ions across the axonal membrane (35).
Through the years many other pumps with similar characteristics have been
discovered such as the gastric H+/K+ ATPase and the sarcoplasmic-reticulum
Ca2+ ATPase that plays an important role in muscle contraction. A common
feature of this class of transporters is the formation of a phosphorylated
intermediate during the reaction cycle (36). The Ca2+-ATPase, Na+/K+ ATPase,
H+/K+ ATPase are very well studied and documented. Studies on these pumps
have revealed several interesting details about the structure and mechanism of
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this family of transporters. All the members of the P-type ATPase family have
four well-defined domains.
The Phosphorylation (P) domain
This domain contains the DKTGTLT motif, which is conserved throughout
the P-type ATPase family. The Asp in this motif gets phosphorylated reversibly
during the reaction. The P-domain in Ca2+ ATPase is roughly spherical and has a
Rossman fold with a central seven stranded β-sheet flanked by α-helices
(37).This domain is homologous to bacterial ATPases (36).
The Nucleotide (N) domain
As the name suggests it is here that ATP binds. The N-domain is a part of
the P-domain. In the Ca2+ ATPase it is a β-sheet made of seven strands. The Ndomain of Na+/K+ ATPase has a similar fold as the Ca2+ ATPase except that the
β-sheet is made up of six and not seven strands (37).
The Actuator (A) domain
The sequence of this domain like the P-domain is highly conserved. It
contains the conserved TGES motif. This domain is not involved in metal
binding. Structural studies indicate that this domain has a β-sheet jelly roll fold
which contains many conserved residues. This domain and especially the
conserved TGES motif comes in close contact with the phosphorylation domain
when the ion is being pumped (37).
The Membrane (M) domain
The membrane domain consists of six to ten membrane helices
depending on the P-type ATPase family. The Ca2+- ATPase and Na+/K+ ATPase
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have 10 transmembrane helices (38). On comparing the sequences of the
membrane region of various ATPases they were found to have very little
sequence homology. However the overall structure of this region is similar. In the
SR- Ca2+-ATPase, Asp800 in M6 and Glu805 in M8 provide ligands for Ca2+
binding (37). The corresponding sites involved in ion translocation in N.crassa H+
ATPase are Asp730 and Glu 805, and in A.thaliana H+- ATPase, it is Asp 684
(39). In addition to these, Val304, Ala305 and Ile307 in M4 are also involved in
binding Ca2+ (37).

Inside

Outside

Figure 1.2. The Post-Albers Cycle based on the Na+/K+ ATPase.
The ion 1 from the interior of the cell binds to the high affinity site in the ATPase
which is the E1 state. Ion binding triggers phosphorylation of the enzyme by
Mg2+-ATP, which leads to the phosphorylated E1-P state. The phosphorylated
E2-P state then forms, which is unable to phosphorylate ADP, and this state has
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a reduced affinity for ion 1, and it goes outside the cell. Ion 2 binds from the
outside and, on hydrolysis of the phosphorylated Asp, the enzyme releases ion 2
to the interior and rebinds ions 1. The enzyme is ready to start another cycle.

Figure 1.3. E1.2Ca2+ and E2 (TG)2 forms of Ca2+ ATPase in the lipid bilayer,
generated by molecular dynamics simulation (37). E1.2Ca2+ is the high affinity
state when the two calcium ions from the interior of the cell are bound to the
ATPase in the E1 state. Ion binding triggers the phosphorylation of the ATPase,
this leads to formation of the E2-P state, which is unable to phosphorylate ADP
and has low affinity for the metal ion. In the figure, the cylinders represent the αhelices, arrows β-strands.
Ca2+ ATPase is about 150 Å high and 80 Å thick, it is made up of a cytoplasmic
head piece, a transmembrane domain which has 10 α-helices (M1-M10), and
small luminal loops (40). Helices M2, M3, M4 and M5 have long cytoplasmic
extensions (37, 40). The cytoplasmic headpiece is made up of the Actuator,
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Nucleotide binding and Phosphorylation domains. In the Ca2+ ATPase the A
domain controls the gating mechanism that in turn controls the Ca2+ binding and
release (37). The N domain contains the ATP binding site. In the phosphorylation
domain, the Ɣ-phosphate reacts with the Asp351 (37). In the E1.Ca2+, the A, N
and P domains are wide apart. A domain is connected to helices M1 – M3, and P
domain to helices M4 and M5. Helix M5 is very long, it functions as the backbone
of the molecule (37). The SR Ca2+ ATPase has two high affinity Ca2+ binding
sites in the transmembrane region (indicated by two purple circles in figure1.3).
When the two Ca2+ ion dissociate to form the E2 state, the three domains which
were wide apart come close together to form a compact structure (37). P domain
inclines 30˚ with respect to the membrane, N domain rotates 60˚ with respect to
the P domain and A domain shifts 110˚ horizontally (37). In the E2 state, helices
M1, M3 and M5 are bent (37). Helices M1-M6 undergo major changes involving
rearrangement (37). Thus, dissociation of Ca2+ ions leads to change in position
of P domain which in turn leads to structural changes in the membrane region.
All P-type ATPases follow the same reaction mechanism. The
Phosphorylation and Actuator domains all function in a similar manner. It is the
N-terminal and the membrane domains that are involved in metal binding,
depending of the class of ATPase their metal ion selectivity changes. Thus each
ATPase has evolved to accommodate metal ions having different size and
geometry (36).
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1.8 Classification of P-type ATPases
On the basis of sequence alignment and substrate specificity this family is
classified into five groups (group’s I-V). Each group is further divided into
subgroups on the basis of substrate specificity (36, 41).
Type IA ATPases
This is a class of bacterial pumps, the E.coli Kdp K+- pump is an example of this
group. Kdp is made up of four different proteins – KdpF, KdpA, KdpB and KdpC.
KdpB is the ATPase that pumps K+ ions and it has six membrane helices (4243).
Type IB ATPase
These transporters were discovered much later. They are simpler in terms
of evolution especially the bacterial pumps. These ATPases are very
widespread, and are present from archea to man. This group of ATPases has
very broad substrate specificity; they are soft transition metal ions. Some of the
examples of this class are the bacterial metal resistance proteins such as CopA,
ZntA and CadA. These pumps assist in maintaining homeostasis of essential
metal ions such as Cu+ or Zn2+ which may be toxic when they are in excess and
also remove toxic ions such as Ag+, Cd2+ and Pb2+ from the cell thus maintaining
the homeostasis of essential ions (36, 44-46).
Type II and Type III ATPases
The previously mentioned sarcoplasmic reticular Ca2+- ATPase, and the Na +/K+
ATPase belong to Type II and the H+ ATPase is an example of class III.
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Type IV and V
Both type IV and V are groups of transporters which are not as well researched
as the other classes of P-type ATPases. Type IV ATPases are found in
eukaryotes, where they are involved in lipid transport and maintenance of lipid
bilayer asymmetry (36). They are also known as lipid flippases. Studies in the
red blood cell and S.cerevisiae have shown that these flippases translocate
phospholipids from the outer to the inner leaflet of plasma membranes (36).
These proteins have similar features as the metal ion transporting P-type
ATPases. The type V family of transporters has features similar to other P-type
ATPases, however their substrate specificities and biological roles are yet to be
studied (36).
1.9 Classification of PIB ATPases
The Zinc Transporting ATPase (ZntA) was identified by our lab in 1997.
ZntA belongs to the P1B family of ATPases. The discovery that the mutations in
Cu+ ATPases were responsible for Menkes and Wilsons disease first drew
attention to this class of pumps in 1993. The widespread presence of these
pumps from archea to humans speaks of the important roles these proteins play
in maintaining metal homeostasis. All the members of this class have 8
transmembrane regions. Helix 6 shows the characteristic CPC motif which is
involved in metal binding (47). Based on the differences in their sequences and
the metal ions they transport, they have been classified into several subgroups.
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Subgroup IB-1
Some of the well studied and characterized proteins such as the Menkes
and Wilsons disease proteins belong to this group. Studies have shown that
these are Cu+ ATPases that transport Cu+ out of the cytoplasm. These pumps
can also transport Ag+ (48-49). These proteins have several metal binding
domains (0-6) in the N-terminal region.
Subgroup IB-2
ZntA belongs to this group. This subgroup of proteins consists of proteins
that drive the efflux of divalent metals such as Zn2+/Cd2+/Pb2+. Some of the
proteins that belong to this class include Synechocystis ZiaA, E.coli ZntA,
S.aureus CadA (50-52). The P1B2 type proteins have been found in archea,
prokaryotes and plants. Both P1B1 and P1B2 have a CPC motif in helix 6 but
distinct sequences in H7 and H8, which differentiates the two groups.
Subgroup IB-3
CopB from E.hirae was the first characterized P-IB3 type ATPase.
Sequence analysis shows that members of this group have a conserved CPH
motif in transmembrane helix 6 and also a histidine rich N-terminal metal binding
domain (47). CopB was originally characterized as a Cu+/Ag+ ATPase, but later
studies showed it to be predominantly activated by Cu2+ transport and partially
activated by Cu+ and Ag+ (45, 53).
Subgroup IB-4
Sequence analysis using membrane prediction software has speculated
that members of this group have only six transmembrane helices with only four
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domains in the N-terminal half of the proteins and two domains downstream of
the characteristic P-type ATPase cytoplasmic loop; however, there has been no
experimental demonstration of this (47). These proteins do not have the Nterminal metal binding domain. Studies on Synechocystis PCC6803 CoaT, a
member of this group have shown that this protein maybe involved in Co2+
transport (47).
Subgroup IB-5 and Subgroup IB-6
Very few members of these groups have been characterized. Their
substrate specificities and residues that participate in metal coordination are not
known (45, 47).
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Group IB-1: Cu+/Ag+

Group IB-3: Cu2+/Cu+/Ag+

Group IB-2:Zn2+/Pb2+/Cd2+

Group IB-4: Co2+?

Group IB-5?

Figure 1.4. The metal specificity and structural characteristics of each subgroup.
1.10 Background on ZntA
ZntA a P-type ATPase is induced by ZntR, which exports not only Zn2+,
but also Pb2+ and Cd2+. ZntA homologues are present in bacteria, archea and
plants. Early studies in our lab have shown that a zntA knock out strain results in
sensitivity to zinc, lead and cadmium (54). This knock out strain did not show any
sensitivity to copper and silver, indicating that in vivo ZntA is very specific for
divalent metal ions (54). Purified ZntA is activated in the presence of Zn2+, Pb2+,
Cd2+ and also Hg2+(50). ATPase activity is highest in the presence of lead. Other
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divalent metals such as Cu2+, Ni2+ and Co2+ also weakly activate the pump. ZntA
has two high affinity metal binding sites one in the hydrophilic N-terminal domain
and the other in the transmembrane region (55).

Figure 1.5. Schematic representation of ZntA showing the different domains and
the conserved residues.

Studies on a truncated form of ZntA called ∆N-ZntA which lacks the cytoplasmic
N-terminal loop have shown that this truncated protein possesses in vitro activity
although the activity is 2-3 fold lower than wild type ZntA for Pb2+, Cd2+ and
Zn2+(56). ∆N-ZntA cloned into ZntA knock out strain when grown in media that
has toxic concentrations of Pb2+, Zn2+ and Cd2+ was able to grow thus providing
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resistance to these metal ions. However, when compared to ZntA the growth rate
was rather slow (57). Stoichiometry measurements by ICP-MS have shown that
∆N-ZntA can bind to only a single metal ion and the metal binding affinity is
similar to the other metal binding site (56). Thus, although the N-terminal domain
is not necessary for the overall activity of the protein it does provide a kinetic
advantage to the enzyme. The N-terminal cytoplasmic region of proteins in the
IB2 subgroup is about 100 residues long.

Figure 1.6. Alignments of the N-terminal domain of members of subgroup P1B-2.

Most of these proteins that belong to P1B2 group have a hydrophilic cytoplasmic
metal binding domain containing one to many copies of a metal binding motif
CXXC. ZntA, in addition to the CXXC motif has an upstream conserved motif
which is CCCDXXC. In the Menkes and Wilsons disease proteins six copies of
the CXXC motif are present (58). Studies on the N-terminal domain of the
Menkes and Wilsons disease related proteins have shown that they can bind to
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many metal ions (59). Solution structure of part of the N-terminal region of ZntA
(residues 46-118) comparing the apo and zinc bound forms have shown that
they have βαββαββ-ferredoxin like fold which is very similar to that of copper
chaperones and to the N-terminal soluble domains of Cu+ ATPases (60). Zn2+
binds to the two cysteines and aspartate of the GMDCXXC motif with tetrahedral
coordination (5). Structural and biochemical data on similar proteins from other
laboratories have shown that presence of different residues changes the metal
selectivity pattern (53, 59, 61).
Biochemical studies in the past have indicated that lead binding to the Nterminus of ZntA requires more than the two cysteines of CXXC; some cysteines
from the upstream CCCDXXC motif may be involved in conferring high selectivity
to lead (56). The N-terminal domain is involved in binding to different metal ions
and when it is absent the activity of the transporter is reduced, indicating that it
may have other functions.
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Figure 1.7. Solution structures of the N-terminal metal binding domains of
L.monocytogenes CadA, E.coli ZntA and B.subtilis CopA. Metal ligands are in
yellow, highly conserved residues in red, and the van der Waals contacts
involving some hydrophobic residues are shown in blue (60).

The Transmembrane region of ZntA
Unlike other groups of the P-type ATPase family, members of P1B group
to which ZntA belongs have a smaller number of transmembrane helices and a
smaller ATP binding loop. ZntA is a much simpler transporter when compared to
the Ca2+ ATPase or the Na+/K+ ATPase where 2 metals are bound in the
transmembrane region. ZntA has 8 transmembrane helices. The transmembrane
region is essential for the activity of ZntA and one metal binding site is located
here. Sequence analysis studies have shown that helices 6, 7 and 8 of ZntA
have conserved residues which may be involved in metal binding and catalysis.
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Figure 1.8. Alignments of H6 of ZntA and its close homologues.

Figure 1.9. Alignment of H7 and H8 of ZntA and its close homologues.

Helix 6 in all P1B type ATPases has a conserved motif, [C/S/T] P[C/H] (X)
4[X/T] XP (figure 1.8). Sequence analysis studies suggest that transmembrane
helices 6, 7 and 8 have conserved residues which may play a role in metal
selectivity. For example, transporters selective for Cu+/Ag+, Zn2+, Pb2+, and Cd2+
have a CPC motif in the sixth helix whereas other ATPases that are selective for
Co2+ or Cu2+ have a conserved SPC and CPH motif (figure1.4) (47, 55).
Mutational studies on the cysteine residues in ZntA from E.coli and CopA from A.
fulgidus have shown that when the cysteines were replaced by other amino acid
residues this leads to complete loss in ATPase activity (47). Studies on the CPC
motif in our laboratory have shown that mutations at each of the cysteines
resulted in loss of ATPase activity and the mutants were unable to bind to metal
ions (55). Mutational studies also indicated that the two Cysteines are essential
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for Pb2+ binding. Serine and Histidine substitutions at these residues did not
affect binding of Zn2+ and Cd2+ but the mutants were unable to confer resistance
to toxic levels of Zn2+ and Cd2+ (55). ZntA and its close homologues that are
selective for divalent metal ions have a conserved aspartate residue in helix 8 in
addition to the CPC motif. None of the other subgroups of the PIB family have a
conserved acidic residue at this position (62). These studies indicate that metal
selectivity is achieved by choosing metal ligands that result in high binding
affinity and also optimal binding geometry.
In helices 7 and 8, there is a single conserved Asn residue at the
cytoplasmic ends of these two helices (figure 1.9). However, sequence analysis
of the P2 and P3 ATPases indicated the presence of a conserved Asp residue in
helix 6, which corresponds to helix 8 in ZntA. Mutations of the Asp800 and
Asp826 from Ca2+ ATPase SERCA1 (P2 ATPase) and Na+/K+ ATPase lead to
complete loss in activity (62) .
Ca2+ ATPase
EALIPVQLLWVNLVTD
DGLPATALGFNPPDLD 815
Na+/K+ ATPase LPLGTITILCIDLGTD
DMVPAISLAYEAAESD 841
ZntA
TTLLGMTGLWLAVLAD
DTGATVLVTANALRLL 732
Figure 1.10. Alignments of H8 of ZntA compared to Helix 6 of Ca2+ ATPase and
Na+/K+ ATPase.
X-ray crystallographic studies on SERCA1 have shown that Asp acts as a
bridging ligand to both the Ca2+ ions in the membrane. Studies on Asp714 in
ZntA performed in our laboratory have shown that this residue in addition to the
CPC motif is a ligand for metal ions, any substitution at this site leads to
complete loss in enzyme activity (62). Biochemical studies indicate that lead
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binding at the transmembrane site involves Asp, and the two Cys but it is slightly
different from Zn2+ and Cd2+ (62). The transmembrane metal binding site like the
N-terminal site binds to different metal ions (Cu2+, Ni2+, Co2+) with high affinity
(63). These studies indicate that conserved residues in the transmembrane
helices contribute to metal specificity and selectivity through correct metal
coordination and geometry.
Table 1.4. Hard –Soft Acid - Base Classification of Metal Ions and Ligands (2).
Metals

Zn2+

Geometry

Ligands

Tetrahedral, Square

O-Carboxylate,

pyramidal

Carbonyl,
S-thiolate, Thioether

Intermediate

N-imidazole
Trigonal, Square Planar,

Pb2+ soft

Octahedral

Sulfur ligands in
RSH, RS-, R2S, S-

Cd2+ soft

Tetrahedral, Octahedral

Thiolate, Thioether,
N-imidazole,

Ag+ soft

Linear, Planar,
Tetrahedral
Linear, Trigonal,

Cu+ soft

Tetrahedral, Octahedral

O-Carboxylate
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1.11 Lead and Cadmium
Cadmium and lead are not essential for organisms. But these metals do
enter the cells by unknown pathways. Studies have suggested that both
cadmium and lead due to similarities with many of the physiologically relevant
metals can compete with these and lead to harmful effects. Lead and cadmium
both have a very high affinity for soft Lewis bases (2). There is a lot of literature
on lead toxicity, unfortunately very little is known about the biochemical
mechanisms or the lead efflux models. ZntA confers resistance and is activated
by Pb2+ < Zn2+ < Cd2+, however it does not confer any resistance to Ag+ and Hg2+
but these metals do activate the transporter (50). When the chemical properties
of these metal ions are compared they have several differences.
Over the past several years all the research on ZntA point to a single fact
that metal selectivity is not a function of metal affinity to the binding site rather
the preferred geometry and coordination to the sites and also the change in
conformation of the protein due to metal binding.
1.12 Aims of the thesis
The major goal of the research presented here has been to study the
structural and biochemical aspects of ZntA which will give us an insight into the
different mechanisms adopted by metal transporting proteins to achieve metal
selectivity. Characterization of conserved cysteine residues in the cytoplasmic Nterminal domain of ZntA and the interaction of this domain with the core
transporter has been presented in this thesis.
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In the first part, research on conserved cysteine and aspartate residues in
the N-terminal domain and their role in metal binding is presented. This
cytoplasmic loop has two cysteine clusters –CCCDXXC- and -GMDCXXC-,
previous studies in our lab have shown that both these cysteine motifs are
required for Pb2+ binding but not Cd2+ and Zn2+ (56). ZntA has two metal binding
sites, one in the membrane region and the other in the N-terminal region and
both are involved in binding Pb2+,Cd2+,Zn2+,Cu2+,Co2+ and Ni2+ with similar affinity
(56). These observations indicate that certain residues from both the motifs may
be involved in contributing to metal selectivity and, in addition, these residues
may also play a role in regulating metal binding geometry and coordination. In
this study, the individual cysteine residues were altered to alanines and the
individual aspartate residues were altered to alanine and asparagine in both the
full length ZntA and in the N-terminal fragment. The effect of these mutations on
the activity of the transporter and metal binding has been described in Chapter 2.
My research also focuses on elucidating the interaction between the Nterminal domain and the membrane domain. Earlier experiments showed that a
mutant of ZntA which lacks the N-terminal domain, ∆N-ZntA, was able to grow in
the presence of Pb2+, Zn2+ and Cd2+ but the growth rate was slower than ZntA.
This indicates that the presence of the N-terminal domain confers an in vivo
growth advantage on ZntA (56). ∆N-ZntA is active in vitro but the activity is 2-3
fold lower than the full length protein, indicating that the N-terminal portion is not
essential for the in vitro activity of the protein but it does provide a kinetic
advantage to the transporter (56). Studies on other P1B type ATPases, such as
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CopA from E.coli suggest the N-terminal domain may interact with metal
chaperones or may be involved in copper regulated trafficking of copper pumps
from intracellular compartments to the plasma membrane (49). Recent studies
on CopA from A.fulgius have shown CopZ, a Cu+ chaperone, delivers Cu+ to the
Cu+ ATPase transmembrane metal binding sites (64). The cytoplasmic metal
binding domain of CopA does not perform this function of metal delivery but it
plays a regulatory role (64). So far no zinc chaperone proteins have been found,
so the important question is how does ZntA get its metal? Our theory, that the
N-terminal domain binds to the metal ion from the cytoplasm and then passes it
to the metal binding site in the transmembrane region, is supported by the results
in the past from ∆N-ZntA, and a site-directed double mutant, C59A/C62A-ZntA.
In this section, the ATPase activity of the transporter was measured in the
presence of N-terminal domain (N1-ZntA) bound to metal as the substrate in
order to determine the catalytic rate at which N1-ZntA bound metal can activate
the transporter. Metal transfer was also measured by transport assays.
Fluorescence energy transfer measurements were performed to study the
interaction between N1-ZntA and ∆N. Chapter 3 of the thesis focuses on an
ongoing project in the laboratory, which involves a characterizing a truncated
form ZntA(Del231-ZntA), which lacks the amino terminal domain and the first
four transmembrane helices. This protein has the conserved CPC motif and Asp
residue which are involved in metal binding. The in vivo resistance profile,
ATPase activity of the transporter and the metal binding stoichiometry have been
examined to investigate effect of loss of the first four transmembrane helices on
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metal selectivity.

The work presented in Chapter 4 is work in progress; the

characterization of the truncated form of ZntA which lacks the first four
transmembrane helices is described.
1.13 Significance of the thesis
Transition metals play innumerable roles in biological systems. They are
essential in several cellular reactions, they may be involved in catalysis by being
a part of enzymes, and they also play an active role in stabilizing structures of
proteins and nucleic acids, thus regulating several downstream biological
pathways. But at the same time they and heavy metal ions can have toxic effects
on cells because when these metal ions are in excess they can bind and react
with several cellular components leading to undesirable consequences. To avoid
these ill effects, organisms have evolved several mechanisms to regulate the
homeostasis by uptake or elimination of essential ions such as iron, copper and
zinc and nonessential ions such as cadmium, lead, mercury and silver (65-66).
There has been an immense amount of research on iron and copper
homeostasis systems for several years. Zinc is unique unlike iron and copper it
does not display any redox activity. It is the second most abundant transition
metal which is associated with several zinc binding proteins (4). There are
several zinc transporters, ZIP family, CDF family (Zit’s, ZnT’s) and the ABC
transporters in mammals. But not much is known of the metal binding,
coordination, geometry and ion selectivity of these transporters. ZntA is a very
good model protein to study the above roles as it is not only a zinc transporter
but it also plays a role in the transport of heavy metals such as lead and
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cadmium which are extremely toxic to cells.

Results presented here are of

significance because they give us an indication of the residues that contribute to
ion selectivity and coordination geometry, and also describe the role of
cytoplasmic N-terminal domain in kinetics, metal binding and transfer. These
results can be used as a basis to explain mechanisms of transition and heavy
metal binding and transport in several proteins involved in metal trafficking.
These studies pave the way in understanding other metalloproteins; metal
transport and trafficking are accomplished by proteins that display bioinorganic
chemistry which is not similar to any of the other well documented
metalloenzymes. The knowledge gained by elucidating the mechanism by which
ZntA functions gives us an insight into how metal transporters work in many
diseases such as Alzheimer’s, Parkinson’s, Acrodermatitis enteropathica,
diabetes, asthma and certain kinds of cancers. Details of metal transporters in
these diseases may provide insights for development of drugs against the above
mentioned diseases.
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CHAPTER 2
CONSERVED MOTIFS IN THE AMINO –TERMINAL DOMAIN OF ZNTA:
THEIR ROLE IN METAL BINDING AND SELECTIVITY OF THE PUMP
The N-terminal domain of ZntA (N1-ZntA) has residues which fall into two
classes: those that are conserved in subgroups 1 and 2 of PIB-type ATPases and
those that are only conserved in closely related homologues of ZntA. My goal
has been to identify the role of these residues in metal binding and also in
providing metal specificity.
2.1 Introduction
Transition metal ions are vital for cellular function and survival. Organisms
have several proteins that maintain metal homeostasis, which are located in the
cytosol, mitochondria and cell surface. One such class of proteins is the P1B
ATPases; these are integral membrane proteins that transport heavy metals
across cell membranes (36). This class of proteins is present in bacteria, yeasts,
nematodes, and mammals. On the basis of sequence homology and substrate
specificity this family has been classified in subgroups for example: PIB-1 which is
specific for monovalent metal ions like Cu+ and Ag+ and PIB-2 which transport,
divalent soft metal ions Zn2+, Cd2+ and Pb2+ (45). ZntA from E.coli and CadA from
S.aureus are representative members of this second group. The reasons behind
this metal selectivity and specificity in the PIB family of transporters are not well
understood, though structural and biochemical studies have provided some
details in this regard. The cytoplasmic N-terminal region of both PIB-1 and PIB-2
transporters have the conserved cysteine rich motif (CXXC) (47); this CXXC
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motif is also present in some copper chaperone proteins and in the bacterial
periplasmic mercury binding protein MerP. The Menkes protein ATP7B contains
six copies of the CXXC motif, which are involved in binding copper and thus
translocating it to the lumen. Proteins such as Atx1 and Ccc2, which play a role
in copper delivery also have the CXXC motif (12). Structural studies of the Atx1,
Ccc2, CopZ and MerP have shown that these proteins share a similar ferredoxinlike (β1-α1-β2-β3-α2-β4) fold (8, 67). Solution structures of part of N1-ZntA
(residues 46-118), comparing the apo and zinc bound forms have shown that it
has a βαββαββ-ferredoxin like fold which is very similar to that of copper
chaperones and to the N-terminal soluble domains of Cu+ ATPases and MerP
(5). Another NMR study has shown that in pumps that transport Zn2+ and Cd2+,
these metal ions are bound in tetrahedral co-ordination to two cysteine residues
and the carboxylate oxygens of a conserved aspartic or glutamic acid residue.
Sequence analysis of the PIB pumps have shown that the conserved motif is
DCXXC or CXXC with a conserved D/E suggesting that an acidic residue is
necessary for conferring divalent metal ion selectivity (60). In addition to the
DCXXC sequence, ZntA and its close homologues from Salmonella typhi and
Klebsiella pneumoniae also have an upstream cysteine rich motif CCCDXXC in
the N-terminal domain (56). Studies in our lab had suggested that this motif is
required for binding lead at the N-terminal site in ZntA, and that this motif is
present in pumps that are highly selective for lead (56). Data have shown that
the membrane domain (∆N-ZntA), which lacks the N-terminal domain, has 2-3
fold lower activity than wtZntA for Pb2+, Cd2+ and Zn2+ (56, 68). It has been
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suggested that the N1-ZntA is not necessary for the overall activity of the protein
but it provides a kinetic advantage to the protein (68). Stoichiometry
measurements by ICP-MS have shown that the isolated domain, N1-ZntA, binds
to lead, zinc, cadmium, copper, nickel and cobalt with a stoichiometry of 1.
Additionally another construct N2-ZntA, where the first 46 residues were deleted
was constructed. N2-ZntA bound to zinc and cadmium with similar stoichiometry
as N1-ZntA but N2-ZntA was unable to bind to lead (56).
M.tuberculosis -------------------------------------------------------MGCEC
CSSC
CS 9
S.aureus

-------------------------------------MSEQKVKLMEEEMNVYRVQGFTC
CANC
CA 27

H.pylori

-------------------------------------------------MQEYHIHNLD
DCPDC
CA 15

B.Subtilis

---------------------------------------------MRLVKQEYVLDGLD
DCSNC
CA 19

S.typhi

CCCEEHC
-MSTPDTDGKKVPPFTSFRLAPAIQKADSCCC
CCC
CASSAPVSTAVAGTRYTWKISGMSC
CAAC
CA 63

ZntA

-MSTPDNHGKKAPQFAAFKPLTTVQNANDCCCD
CCCDGAC
DCAAC
CA 63
CCCD CSSTPTLSENVSGTRYSWKVSGMD

M.tuberculosis -------PSGN-------------------------------------------GNEILVMAAS 23
S.aureus

-------GKFEKNVKKIPGVQDAKVNFGASKIDVYGNASVEELEKAGAFENLKVSPEKLANQTI 84

H.pylori

-------SKLERDLNELDYVKKAQINFSTSKLFLDTSDFE--------------KVKAFIKQNE 58

B.Subtilis

----NCARKIENGVKGIKGINGCAVNFAASTLTVSADGKEE--------QWVTNKVEKKVKSID 68

S.typhi

----------RKVENAVRQIRGVNQAQVLFATEKLVVDADTDLRAQIEHAVQKAGYTLRSEDS 110

E.coli

-----RKVENAVRQLAGVNQVQVLFATEKLVVDADN------------DIRAQVESALQKAGYS 110

Figure 2.1. Alignments of the N-terminal domain of members of P1B-2 group.
In this study, the importance of each individual cysteine residue, as well
as the aspartate residues, in the two cysteine-rich motifs in metal ion binding and
conferring metal selectivity was examined. The effect of alanine and/or
asparagine substitutions on metal binding and in vivo and in vitro activity was
evaluated. Individual alanine mutations at Cys31, Asp32, Cys35, Asp58, Cys59
and Cys62 had reduced ATPase activities and they also lost the ability to bind
lead and cadmium ions. The profile of these mutants for zinc was interesting;
none of the substitutions bound to zinc ion, additionally these mutants exhibited
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lower in vivo and in vitro activity when compared to wtZntA. To understand the
co-ordination environment of lead, zinc and cadmium, and obtain details
regarding ligand environment and geometry, the technique of X-ray Absorption
Spectroscopy (XAS) was used. The XAS experiment and analysis were
performed in collaboration with Dr.James Penner Hahn at University of Michigan.
2.2 Materials
Plasmid pBAD/mycHis-C and E.coli strain LMG194 were obtained from
Invitrogen; plasmid pET16B was obtained from Novagen. Chemicals for the
ATPase activity assay and standard metal solutions were purchased from
Sigma. Metal standards used for inductively coupled plasma mass spectrometry
(ICP-MS) were from VWR.
2.3 Experimental Methods
2.3.1 Construction of N1-ZntA with carboxyl - terminal strep tag
N1-ZntA(residues 1-111 of ZntA followed by a eight residue strep tag) was
created by PCR using the plasmid pZntA as template and the oligonucleotides
5’-CTA CTG TTT CTC CAT ACC C 3’ as forward primer and 5’ GCG CTC GAG
TTA TTT TTC GAA CTG CGG GTG GCT CCA CAG GGA ATA GCC TGC 3’ as
the reverse primer. The amplified PCR product was cloned into pET16b using
Nco1 and Xho1 sites; this was then transformed into E.coli strains TG1 and Bl21.
2.3.2 Construction of C29A, C30A, C31A, D32A, D32N, C35A, D58A, D58N,
C59A, C62A
In order, to identify the residues involved in metal binding sites, several
point mutations were created. All these mutants were created in ZntA using the
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quick change site directed mutagenesis kit and the following nucleotides were
used: C29A - 5’ AAC GCC AAC GAC GCA TGC TGC GAC GGC 3’ and 5’ GCC
GTC GCA GCA TGC GTC GTT GGC GTT C 3’; C30A - 5’ AAC GCC AAC GAC
TGC GCA TGC GAC GGC GC 3’ and 5’ GCG CCG TCG CAT GCG CAG TCG
TTG GCG TTC 3’; C31A - 5’ AAC GAC TGT TGC GCT GAC GGC GCC TGT
TCC 3’ and 5’ GGA ACA GGC GCC GTC AGC GCA ACA GTC GTT 3’; D32A –
5’ AAC GAC TGT TGC TGC GCC GGC GCA TGT TCC 3’ and 5’ GGA ACA
TGC GCC GGC GCA ACA GTC GTT 3’; D32N - 5’ AAC GAC TGT TGC AAC
GGC GCC TGT TCC -3’ and 5’ GGA ACA GGC GCC GTT GCA GCA ACA GTC
GTT-3’; C35A – 5’ TGC GAC GGC GCA GCT AGC AGC ACG CCA AC 3’ and 5’
AGT TGG CGT GCT GCT AGC TGC GCC GTC GC 3’ ; D58A – 5’ GTC AGC
GGC ATG GCA TGC GCC GCC TGT GC 3’ and 5’ GCA CAG GCG GCG CAT
GCC ATG CCG CTG AC 3’; D58N – 5’ GTC AGC GGC ATG AAT TGC GCA
GCC TGT GCG 3’ and 5’ CGC ACA GGC TGC GCA ATT CAT GCC GCT GAC
3’, C59A – 5’ GTC AGC GGC ATG GAC GCC GCG GCC TGT GCG CGC 3’ and
5’ GCG CGC ACA GGC CGC GGC GTC CAT GCC GCT GAC 3’ ; C62A – 5’
GGC ATG GAC TGC GCC GCG GCT GCG CGC AAG GTA G 3’ and 5’ CTA
CCT TGC GCG CAG CCG CGG CGC AGT CCA TGC C 3’. The altered bases
for the mutations are indicated in red. The QuikChange mutagenesis is a 4 step
procedure, where the oligonucleotide primers, each complementary to the
opposite strands of the vector, are extended during temperature cycling by Pfu
\Turbo DNA polymerase. Following temperature cycling the amplified DNA is
then treated with Dpn1 which digests the parental DNA template. The amplified

55
and Dpn digested DNA is then transformed into XL1-Blue supercompetant cells.
Colonies were picked and plasmids purified and checked by digestion with the
corresponding restriction enzyme. The plasmids were also verified by automated
DNA sequencing (WSU). The mutant genes were cloned in pBAD-mycHis C
vector from Invitrogen and expressed in strain LMG194 (zntA::cat), this strain is a
zntA knock out strain. All these mutants were created in the full length construct
with a C-terminal His tag (50).
These mutants were also created in the N1-ZntA fragment. The mutant
ZntA plasmid was used as template and the pBAD-75 (5’-ATA AGA TTA GCG
GAT CCT-3’) and ZntA-N1strepreverse (5’-GCG CTC GAG TTA TTT TTC GAA
CTG CGG GTG GCT CCA CAG GGC ATA GCC TGC-3’) as the
oligonucleotides for PCR. The PCR product and pET16B were digested using
Nco1 and Xho1. Following restriction digestion the pET16B and the amplified
DNA were ligated together to generate the plasmid N1-ZntA with the mutation.
The N1-ZntA was inframe with strep tag at the C-terminus. The sequence was
verified by automated DNA sequencing at WSU.
2.3.3 Protein expression and Purification of the ZntA mutants
The His-tagged full length ZntA mutants were expressed by growing
LMG194 (zntA::cat) cells transformed with the appropriate plasmid at 37˚C
overnight for about 15 hrs in ZY medium (supplemented with 0.5% glycerol,
0.05% glucose, 0.2% alpha lactose, 1mM MgSO4) followed by induction with
0.2% arabinose. Cells were harvested after 15 hrs of growth, washed with icecold buffer containing 25mM Tris, pH 7.0 and 100mM KCl, and cell pellets were
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stored at -20˚C. Protein purification procedures were all performed at 4˚C.
Frozen cells were thawed and resuspended in buffer A (25 mM Tris, pH 7.0, 100
mM sucrose, 1 mM PMSF, 1 mM EDTA and 1 mM β-mercaptoethanol (BME)) at
0.2g/ml. The cells were broken at 20,000 p.s.i using a French press; the lysed
cells were then incubated with DNase 1 (0.02mg/ml) and 2mM MgCl2 for 30 min.
The lysed cells were then centrifuged at 8000 rpm for 30min. The supernatant
was then centrifuged at 40,000 rpm for 1 h to separate the membranes from the
soluble fraction of cells. The pellet from this centrifugation was resuspended in
buffer B (1 mM Tris pH 7.0, 100 mM sucrose, 1 mM EDTA, 1 mM PMSF, and 1
mM BME), stirred for 1 h at 4˚C, and then it was centrifuged at 40,000 rpm for 1
h. The membrane was then resuspended in buffer C (25 mM Tris pH 7.0, 100
mM sucrose, 500 mM NaCl, 1 mM PMSF and 1 mM BME). Triton-X-100 was
added to a final concentration of 1% and the suspension was stirred for 1 h at
4˚C. The solublized membranes were then centrifuged at 40,000 rpm for 1 h to
remove the insoluble fraction. The supernatant was then loaded on a charged
Ni2+-pro-bond column. The column was washed successively with buffer C,
buffer C + 50 mM imidazole, and buffer C + 100 mM imidazole. Finally the
protein was eluted using 30 ml of buffer C with 300 mM imidazole. 1 ml fractions
were collected and analyzed for protein. Protein containing fractions were pooled
and loaded on 40 ml Sephadex G-25 columns to remove imidazole. Protein
fractions were collected and concentrated using YM-100 centricons. The protein
was stored at -80˚C with 10 % glycerol as a cryoprotectant.
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2.3.4 Protein expression and purification of N1-ZntA and N1-ZntA mutants
The strep tagged N1-ZntA was expressed by growing the N1-ZntA
transformed

BL21DE3plysS

strain

at

37˚C

in

Luria

Bertani

medium

supplemented with 100µg/ml ampicillin until the absorbance at 600 nm was 0.8.
This was followed by induction with 0.1 mM IPTG and then the temperature was
lowered to 30˚C. Cells were harvested 4 h after induction, washed with ice-cold
buffer containing 25 mM Tris, pH 7.0 and 100 mM KCl, and cell pellets were
stored at -20˚C.The strep tag is a short peptide (8 amino acids, WSHPQFEK),
which binds with high selectivity to Streptactin, an engineered streptavidin. The
frozen cell pellets were thawed and resuspended in buffer A (100 mM Tris pH
7.0, 150 mM NaCl, and 1 mM EDTA). The cells were broken at 20,000 p.s.i, the
lysed cells were then incubated with DNase 1 (0.02mg/ml) and 2mM MgCl2 for 30
min. The lysed cells were then centrifuged at 8000 rpm for 30 min. The
supernatant was then centrifuged at 40,000 rpm for 1 h to separate the
membranes from the soluble fraction of cells. The supernatant was loaded onto
a 5ml streptactin Sepharose column (IBA Technologies). The column was
washed with 5 bed volumes of buffer A, and then the protein was eluted using 6
times 0.5 column volume buffer A + 2.5 mM desthiobiotin. 1ml fractions were
collected and analyzed for protein. Protein containing fractions were pooled and
loaded on 40 ml Sephadex G-25 columns which were pre-equilibrated with buffer
B (10 mM Bis Tris pH 7.0 and 150 mM KCl) to remove desthiobiotin and EDTA.
Protein fractions were collected and concentrated using YM-3 centricons. The
protein was stored at -80˚C with 10 % glycerol as a cryoprotectant.
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2.3.5 Determination of Protein Concentration
Protein concentrations were determined by Bichinchonic acid assay, using
bovine serum albumin as standard. In this assay the proteins reduce Cu2+ to Cu+
in a concentration dependent manner. Bichinchonic acid forms a purple complex
with Cu+, which has an absorbance maximum at 562 nm. This absorbance is
proportional to the protein concentration. BSA is used to generate a standard
curve.
2.3.6 ATPase Activity Measurements
The activity of ZntA and the ZntA mutants was measured by a coupled
spectroscopic assay, involving pyruvate kinase and lactate dehydrogenase. The
regeneration of ATP is coupled to the oxidation of NADH, which is monitored at
340 nm (50). The buffer for the reaction was 0.05 M Bis tris, 0.1 M acetic acid,
and 0.05 M triethanolamine at pH 7.0. The reaction mixture (1ml) also contained
0.1% asolectin, 0.2% Triton–X–100, 10% glycerol, 5 mM ATP, 0.25 mM NADH,
1.25 mM phosphoenolpyruvate, 7 units of pyruvate kinase, and 10 units of
lactate dehydrogenase, with or without metal ion (Zn2+,Pb2+,Cd2+). The proteins
were reduced by incubation with 2 mM DTT for 1 h prior to the reaction. About
0.5-2mg/ml protein was used per assay. The reaction mixture was incubated for
5 min at 37˚C before initiating the reaction with 5 mM MgCl2.
Thiolates in the assay buffer are known to increase the ATPase activity
(50).The activities of the mutants were also investigated in the presence of
thiolates. Along with the other assay ingredients, thiolates were also added. The
concentration of the thiolate form of cysteine required to generate a constant
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metal ion: thiolate ion ratio was calculated using the Henderson-Hasselbach
equation, using a pKa of 8.33 for cysteine and a pH of 7.0.The data obtained
was fit to the Michaelis-Menten equation,
v = Vmax x S/ (KM + S)
where, Vmax equals the maximum velocity, S is the concentration of metal, KM is
the Michaelis constant for the substrate metal ion(50).
2.3.7 Measurement of Metal Binding Affinity of the N1-ZntA mutants
The purified N1-ZntA and N1-ZntA mutants were incubated with 1mM Tris
(2-carboxy-ethyl) phosphine hydrochloride (TCEP) for 1 h on ice. The buffer
(10mM Bis-tris, pH 7.0) and metal solutions were deoxygenated and equilibrated
with argon. The TCEP was removed by passing the protein on a 10 ml Sephadex
G-25 column under partially anaerobic conditions. For the fluorescence titration,
the reduced protein was titrated with increasing concentration of different metal
solutions (Zn2+, Pb2+, and Cd2+). The metal solutions were added to the reduced
protein using gas tight Hamilton syringe in a sealed cuvette. After each addition
the solution was mixed well, and the fluorescence spectrum collected. The
protein was excited at 290nm and an emission spectrum between 300-500nm
was measured.
2.3.8 Preparation of Metal bound N1 and N1-mutants
To measure the stoichiometry of metals bound to N1-ZntA and the sitespecific mutants, the protein was reduced with 1 mM TCEP for 1 h at 4 ˚ C. The
reduced protein was then incubated with metal salts for 1 h at 4˚ C, the excess
metal was removed by passing through a Sephadex G–25 column (56).
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2.3.9 Measurement of Metal Binding Stoichiometry of the N1-ZntA mutants
by ICP-MS
The metal content was measured by a PE Sciex Elan 9000 ICP-MS
(inductively coupled mass spectrometry) with a cross-flow nebulizer and Scott
type spray chamber. The RF power was 1000 W, and the argon flow was
optimized at 0.92 L/min. The optimum lens voltage was centered on rhodium
sensitivity. The data were collected as counts per second. Lead, Cadmium and
Zinc standards were obtained from VWR. Standard calibration curves were
determined from samples diluted from stock solutions of 1000 ppm standard
solutions. The samples and standards solutions were all diluted in 2% HNO3.
2.3.10 Sensitivity to metal salts
The sensitivity of E.coli strains LMG194, LMG194 (zntA::cat) and LMG194
(zntA::cat) transformed with pZntA, or the site specific mutants, to lead, cadmium
and zinc was measured. The cells were grown in low phosphate media, pH 7.5.
Cells were grown overnight and then diluted 100 fold in the same media in the
presence of lead acetate, zinc chloride, and cadmium chloride. Cell growth at 37
˚C was monitored at 600 nm over a period of 24 hours (56, 69).
2.3.11 X-Ray Absorption Spectroscopy (XAS)
XAS was used to study the coordination geometry and ligand environment
of metal bound to wild type N1-ZntA. This experiment was performed in
collaboration with Dr. Jim Penner-Hahn’s laboratory at University of Michigan.
XAS samples of different metals bound to N1-ZntA were prepared as follows.
The purified proteins were reduced with 1mM TCEP for an hour. The protein was
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then passed through a 10ml Sephadex G-25 column pre-equilibrated with 10mM
Bis-Tris to remove the reducing agent, under anaerobic conditions. The reduced
apo-proteins (~1 mM) were incubated with 0.9 equivalents of metal salt solutions
for 1 h on ice. The protein was then passed through a 10 ml Sephadex G-25
column pre-equilibrated with 10 mM Bis-Tris to remove any unbound metal.
Protein concentrations of the fractions collected were checked by the
Bichinchonic acid assay. The protein fractions were pooled and concentrated to
about ~50µl, 30% glycerol was mixed with the protein for uniform glass
formation. The final protein concentration was determined by BCA and the final
metal content of the protein was determined by ICP-MS. Then the samples were
loaded in Lucite cells, with Kapton tape window and immediately frozen in liquid
nitrogen. XAS data for all the N1-ZntA samples were collected at the Stanford
Synchroton Radiation Laboratory (SSRL) beamline 9-3. Harmonic rejection was
achieved by using a pair of Rh-coated mirrors. For Co, Cu, Zn, Cd: K-edge
fluorescence excitation spectra, and for Pb:L3-edge fluorescence excitation
spectra, were collected using a Canberra 30-element Germanium solid-state
detector array equipped with a filter and Soller slits focused on the sample.
During data collection, the sample temperature was maintained between 10-14 K
using the Oxford Instruments continuous-flow liquid-helium cryostat. Three
nitrogen filled ion chambers were used to measure the X-ray intensity at different
points along the photon path. The first ion-chamber was placed in front of the
sample to measure the incident intensity (I0), the second ion-chamber was
placed just after the sample to measure the transmitted intensity (I1) and there
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was a third ion-chamber (I2) that was placed after I1. The X-ray energies were
calibrated by collecting the absorption spectra of the reference metal foils
simultaneously with those of the proteins (e.g. Co foil with the Co-N1 sample).
The spectra were measured using 5 eV steps in the pre-edge region, 0.3 eV
steps in the edge and 0.05 Å-1 increments in the extended X-ray absorption fine
structure (EXAFS) region with integration times ranging from 1 to 25 s in a k3weighted manner giving a total scan time of 25 to 40 minutes (total scan time
was different for different metals) per scan. Six to twelve scans were collected for
each protein sample depending on the metal concentration and each metalbound sample was prepared in duplicates to check reproducibility. Each channel
for each scan was checked for spectral anomalies and all the channels with
significant glitches (2−3 channels per scan) were discarded before averaging. In
order to test for possible radiation damage, the first and the last scan for each
sample were compared. No change was observed for any metal-bound samples.
The data were calibrated, reduced and averaged using the EXAFSPAK
suite of programs (George, G.N. Stanford Synchroton Radiation Laboratoty,
Menlo Park, CA, 1990.). The first inflection points of different metal foils were
assigned at certain values for calibration of the data. The averaged data were
background subtracted and normalized to give the final spectra (70). The data
were then converted to k-space using the equation k =

2me( E − E 0) / h 2 where E

is the incident photon energy and E0 is the threshold (binding) energy of the core
electron. In our calculation E0 was 7725 eV for Co, 9000 eV for Cu, 9680 eV for
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Zn, 13055 eV for Pb and 26730 eV for Cd. The EXAFS data can be described by
the equation: χ ( k ) = ∑
s

NSAS ( k ) S AS ( k )
exp( −2k 2σAS2 ) sin ( 2k R AS + φAS ( k ))
kR 2AS

where Ns is the number of scatterers at a distance RAS, As(k) is the effective
backscattering amplitude, SAS is a scale factor, σ2AS is the Debye-Waller factor
i.e. the mean-square disorder, φAS(k) is the total phase shift experienced by the
photoelectron and the sum is taken over all shells of scattering interactions. The
Fourier transforms were calculated using k3-weighted data over a k range from
2−12 Å-1 to 2−15 Å-1 for different metals. Experimental data were fit with
theoretical EXAFS amplitude and phase functions calculated using FEFF 7.02.
Single scattering parameters were calculated for M−O, M−S and M−M using
appropriate bond lengths taken from the Cambridge Structural Database (CSD)
for each metal.RAS and σAS were varied, Ns was held fixed at reasonable integer
values.
2.4 Results
2.4.1 The in vivo resistance activity of N1-ZntA mutants to Pb2+, Zn2+ and
Cd2+ in the growth medium
The zntA deleted E.coli strain, LMG194 (zntA::cat) is sensitive to toxic
levels of Pb2+, Zn2+ and Cd2+; it is unable to grow even after 24-30 h and this
sensitivity can be complemented by wtzntA. The cysteine (C29A, C30A, C31A,
C35A, C59A and C62A) and the aspartate (D32A, D32N, D58A, D58N) mutants
were tested for their ability to confer resistance to Pb2+, Zn2+ and Cd2+. For
comparison, the ∆N-ZntA mutant, in which the N-terminal domain is deleted, was
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also tested. All the site-specific mutants were able to confer resistance to Pb2+,
Zn2+ and Cd2+, better than the ∆N-ZntA mutant. In the presence of zinc, a slight
lag was observed for some mutants compared to ZntA itself.

Figure 2.2. Resistance to Lead, Zinc and Cadmium salts by the wild type strain
LMG194, the zntA-deleted strain LMG194(zntA::cat), and the deleted strain
transformed with the plasmids containing wtzntA, ∆N-ZntA and the site-specific
mutants in the N-terminal domain.
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Figure 2.2. Resistance to Lead, Zinc and Cadmium salts by the wild type strain
LMG194, the zntA-deleted strain LMG194(zntA::cat), and the deleted strain
transformed with the plasmids containing wtzntA, ∆N-ZntA and the site-specific
mutants in the N-terminal domain.
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2.4.2 Activity of the Purified N1-ZntA mutants
The ATPase activity of ∆N-ZntA, ZntA and the site specific mutants at the
N-terminal domain were measured for the metal ions Pb2+, Zn2+ and Cd2+.
Previous studies showed that the metals ions stimulate the ATP hydrolysis
activity of wtZntA, with Pb2+ exhibiting the highest activity (Table2.1) (50).
Previous studies in the lab have also shown that there is a 4-8 fold increase in
the ATPase activity of ZntA in the presence of thiolate forms of cysteine or
glutathione in the assay medium. This is perhaps because the metal thiolate
complex is a better substrate; within the cell metal ions are expected to be
present as complexes of small molecule chelators such as cysteine or
glutathione (50). The activities obtained for wtzntA in the presence of metal ions
and thiolate form of cysteine in the ratio 1:1 for Pb2+, Zn2+ and Cd2+ were ~2500,
~ 800 and 1000 nmol/(mg.min), respectively (Tables 2.1,2.2,2.3). All the mutants
showed higher activities in the presence of the thiolate form of cysteine.
For the alanine substitutions at Cys29, Cys30, and Cys35, the lead and
cadmium stimulated activity was similar to that of ZntA (Table 2.1).The mutants
C31A, D32A, D32N D58A, D58N, C59A, and C62A showed a 2-3 fold decrease
in activity for Pb2+ (Table 2.1). All the mutants showed higher activities in the
presence of the thiolate form of cysteine. However, mutations at C31, D32, D58,
C59 and C62 showed lower activities in comparison to wtZntA, when the lead:
thiolate complex was provided as the substrate.
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Table 2.1. Kinetic Parameters obtained for ZntA, ∆N and the mutants for Pb2+ in
the absence and presence of the thiolate form of cysteine present at a
concentration equal to the Pb2+ concentration.
Pb2+

Pb2+ + Thiolate

Vmax

KM

Vmax

KM

nmoles/mg/min

µM

nmoles/mg/min

µM

ZntA

584 ± 30

5 ± 0.9

2500 ± 70

166 ± 16

∆N-ZntA

320 ± 6

11.6 ± 0.8

1095 ± 67

55 ± 11

C29A

574 ± 9.5

2.8 ± 0.2

2194 ± 34

89 ± 4.3

C30A

557 ± 15

5.7 ± 0.85

2066 ± 51

66 ± 5.6

C31A

264 ± 8

10 ± 1

1756 ± 56

115 ± 10

D32A

284 ± 8

8.4 ± 0.8

1422 ± 28

37 ± 3

D32N

317 ± 22

6.7 ± 2.3

817 ± 30

70 ± 8

C35A

611 ± 30

14 ± 2

2361 ± 54

249 ± 13

D58A

201 ± 3.4

3 ± 0.27

954 ± 26

26 ± 3.2

D58N

325 ± 20

11 ± 2

1145 ± 69

268 ± 37

C59A

263 ± 5

7.7 ± 0.53

1198 ± 27

236 ± 12

C62A

132 ± 3.8

3.2 ± 0.46

1045 ± 16

47 ± 2.7

All the alanine substitutions and the asparagine substitutions at the
conserved cysteine and aspartate residues displayed 2-3 fold lower activities in
the presence of Zn2+ (Table2.2). Zinc:thiolate induced activities of the mutants is
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higher. However, substitutions at C31, D32, D58, C59 and C62 showed lower
activities in comparison to wtZntA, when zinc: thiolate complex was provided as
the substrate.
Table 2.2 Kinetic Parameters obtained for ZntA, ∆N and the mutants for Zn2+ in
the absence and presence of the thiolate form of cysteine present at a
concentration equal to the Zn2+ concentration.
Zn2+

Zn2+ + Thiolate

Vmax

KM

Vmax

KM

nmoles/mg/min

µM

nmoles/mg/min

µM

ZntA

250 ± 13

10 ± 2

710 ± 28

96 ± 11

∆N-ZntA

81 ± 7

9.3 ± 1.2

372 ± 6

42 ± 3

C29A

86 ± 5.5

7 ± 1.6

1096 ± 28

36 ± 3.8

C30A

92 ± 3.25

3 ± 0.87

1005 ± 30

148 ± 13.4

C31A

61 ± 1.48

2.24 ± 0.31

786 ± 16.2

105 ± 6.5

D32A

85 ± 3

3.2 ± 0.6

748 ± 10

71 ± 3.1

D32N

127 ± 13

15 ± 4.8

753 ± 11.8

94 ± 9.7

C35A

75 ± 1.8

4.7 ± 0.47

697 ± 19

154 ± 11

D58A

82 ± 3

3.8 ± 0.65

587 ± 7.4

75 ± 3

D58N

100 ± 9.7

16 ± 4

730 ± 19

74 ± 5.4

C59A

60 ± 2

3.22 ± 0.5

568 ± 21

127 ± 13.7

C62A

51 ± 1

4.7 ± 0.4

526 ± 15

70 ± 7.2
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The cadmium stimulated activity for the alanine substitutions at Cys29,
Cys30, and Cys35, was similar to that of ZntA (Table2.3). C31A, D32A, C59A
and C62A showed slightly lower activities in the presence of Cd2+.
Table 2.3. Kinetic Parameters obtained for ZntA, ∆N and the mutants for Cd2+ in
the absence and presence of the thiolate form of cysteine present at a
concentration equal to the Cd2+ concentration.
Cd2+

Cd2+ + Thiolate

Vmax

KM

Vmax

KM

nmoles/mg/min

µM

nmoles/mg/min

µM

ZntA

250 ± 13

10 ± 2

710 ± 28

96 ± 11

∆N-ZntA

81 ± 7

9.3 ± 1.2

372 ± 6

42 ± 3

C29A

59 ± 1.3

2.2 ± 0.28

1103 ± 19.7

118 ± 6.11

C30A

84 ± 3

4.6 ± 1.2

1309 ± 95

226 ± 39

C31A

15 ± 1.8

7.3 ± 2.5

818 ± 16

23 ± 2.1

D32A

22 ± 2.4

3 ± 1.3

744 ± 13

69 ± 4.2

D32N

56 ± 4

0.3 ± 1.3

566 ± 13

14 ± 1.7

C35A

97 ± 6.66

6.9 ± 1.4

1041 ± 31

250 ± 17

D58A

76 ± 2

3.3 ± 0.35

703 ± 17

27 ± 3

D58N

57 ± 4

2.5 ± 0.8

552 ± 48

42 ± 14

C59A

52 ± 3

2.27 ± 0.6

635 ± 6.4

129 ± 3.7

C62A

26 ± 3.7

6 ± 1.12

872 ± 16

28 ± 2.2
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2.4.3 Stoichiometry of Metal Binding to N1-ZntA mutants using ICP-MS
To understand the importance of the cysteine and aspartate residues in
the CCCDXXC and the DCXXC in binding metal ions, we determined the metal
binding stoichiometries of the mutants in the isolated fragment N1-ZntA, purified
with a strep – tag (Table 2.4). Wild-type N1-ZntA can bind to one metal ion with
high affinity (56). Binding stoichiometry for C29A, C30A, and C35A was 1 for
Pb2+ and Cd2+. The results indicate that the alanine and asparagine substitutions
at C31, D32, D58, C59, and C62, disrupted the binding of Pb2+ and Cd2+ while
residues C29, C30 and C35 appear not to be important in binding these two
metal ions. Surprisingly, it was observed that any mutations in the upstream
CCCDXXC and downstream DCXXC motifs affected zinc binding completely,
though earlier studies showed that Zn2+ binding was unaffected when the
upstream motif was deleted in a ∆46-ZntA mutant, which lacks the first 45
residues (5, 56).
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Table 2.4. Stoichiometry of Metal bound to N1-ZntA and N1-ZntA mutants using
Inductively Coupled Plasma Mass Spectrometry (ICP-MS); x = No Binding.

Lead

Zinc

Cadmium

N1-ZntA

1 ± 0.0

1 ± 0.1

1 ± 0.0

C29A-N1ZntA

1 ± 0.0

x

1 ± 0.0

C30A-N1ZntA

1 ± 0.0

x

1.1 ± 0.0

C31A-N1ZntA

x

x

x

D32A-N1ZntA

x

x

x

D32N-N1ZntA

x

x

x

C35A-N1ZntA

1 ± 0.0

x

0.8 ± 0.0

D58A-N1ZntA

x

x

x

D58N-N1ZntA

x

x

x

C59A-N1ZntA

x

x

x

C62A-N1ZntA

x

x

x

2.4.4 Affinity of Pb2+, Zn2+ and Cd2+ for the amino terminal metal binding
site mutants using direct fluorescence quenching
The N–terminal domain has one tryptophan residue. The fluorescence
emission of the tryptophan residue is quenched when this isolated domain binds
metal ions. This tryptophan fluorescence quenching is a useful method to
measure the affinity of different divalent metal ions. A titration of N1-ZntA with
increasing concentrations of Pb2+ is shown in Figure 2.3; similar decreases in
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fluorescence were observed for Cd2+ and Zn2+ also. The change in fluorescence
intensity at 340 nm was plotted vs. the metal ion concentration in Figure 2.4. The
data were fit to the following equation (using Kaleidagraph) that assumes a 1:1
binding model for the protein.
N1-ZntA + M2+ ↔ N1-ZntA·M2+
KE = [E·M2+]/ [E ][M2+ ]

Equation(2)

where KE is the association constant of the metal and protein, [E], [M2+] and
[E·M2+] are the concentrations of initial enzyme, initial metal and metal complex
with enzyme. The association constants calculated from the titration data are
summarized in Table 2.5. The affinity of the buffer, Bis-Tris was taken into
account when fitting the data. Mutants C31A, D32A, D32N, D58A, D58N, C59A,
and C62A did not show any fluorescence quenching, suggesting they were
unable to bind lead, in agreement with the results from ICP-MS.
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Figure 2.3. Representative spectra obtained during titration of 10 µM N1-ZntA
with increasing concentrations of Pb2+ (0-15 µM) in 10 mM Bis-Tris, pH 7.0 at
20˚C. The arrow denotes the decrease in fluorescence as increasing amounts of
Pb2+ are added.
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Figure 2.4. Plot of change in fluorescence emission at 340 nm from Figure 2.5
above as a function of the added lead salt concentration. The data were fitted to
equation 2.
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Table 2.5. Association constants for the binding of lead, zinc and cadmium to the
N1-ZntA mutants.

Lead

Zinc

Cadmium

M-1

M-1

M-1

N1-ZntA

(1.8 ± 0.8) x 109

(4.9 ± 2) x 107

(3.6 ± 0.9) x 107

C29A

(8.1 ± 4.5) x 109

x

(5.24 ± 2) x 107

C30A

(4.6 ± 2.5) x 109

x

(1.13 ± 0.5) x 107

C35A

(2.35 ± 0.9) x 109

x

(6.2 ± 2.2) x 107

2.4.5 Analysis of Lead, Zinc, Cadmium, Cobalt and Copper binding by X-ray
absorption spectroscopy
Although structural information of a portion of N1-ZntA bound to zinc has been
solved, details regarding the co-ordination environment of lead and cadmium
bound to N1-ZntA are not available. Here, XAS has been used to study the
structure of lead, zinc, cadmium ions bound to N1-ZntA, thus providing detailed
information with respect to ligand environment and geometry. The co-ordination
environment of cobalt and copper bound to N1-ZntA was also examined,
because our metal stoichiometry experiments suggested that cobalt binding to
N1-ZntA is sub stoichiometric unlike the other metal ions, and in the case of
copper, to test whether N1-ZntA can bind to Cu2+, since it has the CXXC motif,
observed in Cu+-transporting pumps.

76
N1-ZntA-Lead
The N1-ZntA-Pb complex is best simulated with 3 sulfur ligands at a
distance of 2.66 Å. Normalized L3-edge spectra of N1-ZntA-Pb sample is
presented in Figure 2.5a .The EXAFS data were extracted using the value of E0
= 13055 eV. The EXAFS data and the Fourier Transform of the EXAFS (k range
of 1-14 Å-1) are plotted in Figure 2.5b. The data are in blue and fits are in red
dotted lines. The best fit results are presented in Table 2.6. No significant
second shell interaction was found for any of them.
Normalized X-ray near edge spectra
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Figure 2.5a. Normalized edge spectra of Pb L3-edge for the N1-ZntA-Pb
sample.
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Figure 2.5b. EXAFS data and fit for the N1-ZntA-Pb sample.

Figure 2.5c. Graphical representation of approximate lead coordination
geometry.
N1-ZntA-Zinc
The N1-ZntA-Zn sample was best modeled to two oxygen and two sulfur
atoms. The normalized K-edge spectra of Zinc are presented in Figure 2.6a.
The EXAFS data were extracted using the value of E0 = 13055 eV. The EXAFS
data and the Fourier Transform of the EXAFS (k range of 1-14 Å-1) are plotted in
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Figures 2.6b. The data are in blue and fits are in red dotted lines. The best fit
results are presented in Table 2.6.
Normalized X-ray near edge spectra
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Figure 2.6a. Normalized K-edge spectra of N1-ZntA-Zn sample.
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Figure 2.6b. EXAFS data and fit for N1-ZntA-Zn sample.
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Figure 2.6c. Graphical representation of approximate zinc coordination
geometry.
N1-ZntA-Copper
Cu k-edge spectrum of the N1-ZntA-Cu sample is normalized and
presented in Figure 2.7a. From the energy of the edge jump it is evident that the
oxidation state of the metal is Cu+, though the sample was prepared by
incubating the reduced N1-ZntA with Cu2+ in the absence of any reductant. The
XANES feature at the energy of 8983.5 eV is consistent with the 1s→4p
transition of the Cu+ center and also similar with those of the trigonal Cu+ model
complexes (71). The EXAFS data were extracted using the value of E0 = 9000
eV. The EXAFS data and the Fourier Transform of the EXAFS (k range of 1-12.7
Å are plotted in Figs 2.7b and 2.7c. The data are in blue and fits are in red dotted
lines. The best fit results are presented in Table 2.6. The first shell interaction for
Cu+ can be best modeled by 3S ligands at a distance of 2.26 Å. This Cu-S
distance is in agreement with the trigonal geometry and is longer than the linear
Cu-S distance (~2.17 Å). The second shell interaction can only be modeled by a
Cu-Cu interaction pointing towards the formation of a binuclear Cu complex in
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solution, which is in agreement with the XAS studies of ATP7B Wilson disease
protein (72).
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Figure 2.7a. Normalized K-edge spectra of N1-ZntA-Cu sample.
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Figure 2.7b. EXAFS data and fit for N1-ZntA-Cu sample.
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N1-ZntA-Cobalt
From the edge spectra (Figure 2.8a) we can conclude that the Co is in the
+2 oxidation state with a weak pre-edge peak at around 7709 eV. The EXAFS
data were extracted with E0 = 7725 eV. The k3 weighted EXAFS data and Fourier
Transform (k =1-15 Å-1) are presented in Figures 2.8b. The data is plotted in blue
and the fit is in red dotted line. The best fit parameters are presented in table
2.6. From the fitting results Co2+ appears to be in a distorted tetrahedral
geometry. The first shell peaks can be best modeled with a mixture of both O/N
and S interactions with 1 O/N and 3S around the Co2+ center. Our previous
results have shown that binding of Co2+ to N1-ZntA was sub stoichiometric,
suggesting that one Co2+ bridges two protein molecules.
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Figure 2.8a. Normalized Co (II) k-edge absorption spectrum in N1-ZntA-Co
sample.
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Figure 2.8b. EXAFS and Fit for the N1-ZntA-Co sample.
N1-ZntA-Cadmium
Cd k-edge spectrum of the Cd-Znta sample is normalized and presented
in Figure 2.9a. The EXAFS data were extracted using the value of E0 = 26730
eV. The EXAFS data and the Fourier Transform of the EXAFS (k range of 1-15
Å-1) are plotted in Figures 2.9b & 2.9c. The data are in blue and fits are in red
dotted lines. The best fit results are presented in Table 2.6. From the best fit
results it is difficult to predict whether the Cd is present in a 5 or 6 coordinate
environment. The first shell interaction for Cd can be best modeled by either
3O/N and 2S or 3O/N and 3S ligands. The low z ligands O/N are present at a
distance of 2.35 Å and the S ligands are present at a distance of 2.57 Å. Though
the goodness of fit value is better for the 5-cocordinate fit, the Debye-Waller
factors for both O/N and S are very low. The second shell interaction can be
modeled by a Cd-Cd interaction pointing towards the formation of a binuclear Cd
complex in solution.
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Normalized X-ray near edge spectra
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Figure 2.9a. Normalized Cd (II) k-edge absorption spectrum in N1-ZntA-Cd
sample.
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Figure 2.9b. EXAFS and 5 co-ordinate fit for the N1-ZntA-Cd sample.
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Figure 2.9c. EXAFS and 6 co-ordinate fit for the N1-ZntA-Cd sample.
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Table 2.6. EXAFS Fitting results for Lead, Zinc, Cadmium, Copper and Cobalt.
σ2 x103
Sample

Liganda

CNb

R (Å)c

(Å2)d

∆ E0

F x10-3 e

Lead

S

3

2.66

2.81

-16.6

0.2083

Zinc

O

2

2.0

3.90

-13.4

0.3545

S

2

2.31

1.73

S

2

2.58

1.00

Cd

1

3.29

8.36

-4.83

0.8174

O

3

2.35

1.08

S

3

2.57

3.23

Cd

1

3.28

3.28

O

3

2.35

2.35

S

3

2.26

5.04

Cu

1

2.70

9.53

S

3

2.26

3.38

Co

1

1.90

2.09

Cadmium

Copper

Cobalt

-6.42

0.8453

-14.4

0.1598

-12.006

0.8785

a = Scattering atoms, b = Average metal-ligand coordination number,
c = Average metal – ligand bond length, d = Average Debye Waller factor,
e = number for degrees of freedom weighted mean square deviation between
data and fit
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2.5 Discussion
The amino terminal domain of PIB type ATPases has been studied, but
very little is known about the molecular basis of metal selectivity and specificity
of this family of proteins. Sequence analysis has shown that the CXXC motif is
present in copper and lead/zinc/cadmium transporting ATPases; it is also
present in some other proteins including copper chaperones and mercury
binding proteins. Studies of the Cu+ ATPases, which can have multiple copies of
CXXC motif, and CadA, a Cd2+-ATPase, have demonstrated that the cysteines in
this motif are metal binding ligand sites (8). ZntA not only has the CXXC motif
but also a CCCDCXXC motif in its amino terminal domain. ICP-MS
measurements have shown that N1-ZntA binds to a wide variety of metal ions
with a stoichiometry of one, with the exception of cobalt. The N-terminal domain
of the Cu+ ATPase also binds to different metal ions: Cu+, which is a substrate,
and to zinc and cadmium which are not substrates, through different geometry
(10, 61). Some PIB ATPases like the Cu2+ ATPases have a histidine rich amino
terminal domain which may be specialized for binding to divalent copper, some
others like the cobalt transporters do not have the amino terminal domain (47).
Thus it is observed that PIB ATPases have different conserved metal binding
motifs in the N-terminal domains that maybe involved in conferring metal
selectivity. Previous results in the lab have suggested that the extra cysteines
located upstream of the CXXC motif play a role in lead binding (56). To
investigate further the residues involved in conferring selectivity in ZntA, we
constructed individual alanine mutants and additionally the Asp32 and Asp58
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were mutated to asparagines. The residues were replaced by alanine to avoid
any possibility of side chains acting as metal ligand. In D32N and D58N, the
carboxylate oxygens of aspartate side chain were replaced by the amide of
asparagine to examine if a charged residue at this position is essential for the
activity and the metal binding. In vivo, all the mutants display similar resistance
profile as wtzntA for lead and cadmium, but Cys31, Cys59, Cys62, Asp32,
Asp58, Asn32 and Asn58 all show a slight lag in the presence of zinc
(Figure2.2). The individual alanine substitutions at Cys31, Cys59, Cys62, Asp32,
Asp58 and the asparagine substitutions at Asp32 and Asp58 showed 2 fold
lower ATPase activity with lead and 2-3 fold lower activity for zinc and cadmium
when compared to wtzntA (Tables 2.1,2.2,2.3). In vivo, metals are bound to
different chelators such as citrates, histidines or thiolates. When the metal is
provided as a metal thiolate complex in the assay medium, a 4-8 fold increase in
the ATPase activities of ZntA for lead, zinc and cadmium is observed. When
metal thiolate complex was provided as the substrate, the thiolates increased the
ATPase activity of the mutants with lead, cadmium and zinc. The lead: thiolate
complex induced activity of Cys31, Cys59, Cys62, Asp32, Asp58, Asn32, and
Asn58 showed a 5-6 fold increase, and the cadmium, zinc thiolate activities for
the mutants were similar to that of wtzntA (Table 2.1, 2.2, 2.3). This may be
because the thiolates may compensate for the replaced cysteine and aspartate,
thus increasing the activities of the mutants.
Previous metal binding studies, both by ICP-MS and by metal titration,
show that N1-ZntA has a single high affinity metal binding site; it binds to a single
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lead, zinc and cadmium ion. The mutants in N1-ZntA: - C29A, C30A, C35A are
able to bind to lead and cadmium with a stoichiometry of 1 with high affinity, this
was expected since they showed in vitro activities comparable to wtzntA (Table
2.4). Values of lead and cadmium binding affinity obtained for C29A, C30A and
C35A were similar to those obtained for N1-ZntA (Table 2.5).Thus, C29, C30
and C35 are not involved in binding lead or cadmium. However the mutants at
C31, D32, D58, C59 and C62 were unable to bind lead and cadmium,
suggesting that these residues played a role in binding these two metal ions.
Surprisingly none of the N1-ZntA mutants were able to bind zinc. Zinc has a very
small ionic radius (0.88Å), and it is much smaller than lead and cadmium (4).
Structural studies of a portion of the N-terminal domain of ZntA (residues 46118) has been solved; from this it was observed that zinc binds with a tetrahedral
coordination to the two cysteine and the aspartate residue of the GMDCXXC
motif and has no contribution from the upstream motif (5). Our results suggest
that the upstream cysteines together with the Asp32 form a structure that
precludes any kind of interaction of the upstream site with the downstream zinc
binding site, leaving the DCXXC site free to bind zinc. To probe the local
structural environment of zinc, lead and cadmium metal bound to N1-ZntA metal
binding site, X-ray absorption spectroscopy was used. The binding of lead,
cadmium and zinc at the amino terminal site is different for each of these metal
ions. Lead binds with a trigonal geometry to the two cysteines of the CXXC and
Cys31 of the upstream motif, this coordination environment is similar to Pb2+
binding in some proteins in thiol rich environments (Figure2.5, Table 2.6) (63).
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Similar to the solution structure of the Zn2+ bound form of N2-ZntA, zinc bound to
N1-ZntA with 4 co-ordinate geometry to two sulfurs (Cys59 and Cys62) and two
oxygens; one of the oxygens is from the Asp58 and the other may be from water
or the upstream Asp32 (Figure 2.6, Table 2.6)(7).
In CadA, a Cd2+ ATPase from Listeria monocytogenes, Cd2+ is bound
with a tetrahedral geometry at the N-terminus by two Cys and two oxygen atoms
of a conserved acidic residue located at a distance (60). Sequence alignments of
the N-termini of CadA, ZntA and CopA like proteins have shown that all these
proteins have a conserved CXXC motif. CadA like sequences have a conserved
acidic residue Glu61 located in loop 5 which is spatially positioned near the
CXXC motif, but in the case of ZntA homologues there is a conserved Asp in
loop1; solution structure has demonstrated that it is involved in zinc binding.
However, in Cu (I)-ATPases this acidic residue is absent. This indicates that the
presence of the acidic residue provides an appropriate coordination sphere for
divalent metal ions such as zinc and cadmium. In N1-ZntA, since the carboxylate
ligand is located adjacent to the metal cysteine ligands, the metal binding site is
better fit for zinc which is a smaller ion than cadmium.
Unlike CadA, EXAFS data suggest that cadmium bound to N1-ZntA
displays 5 or 6 coordinate geometry. Structural studies on CadA have also
shown that it forms a homodimer containing one cadmium atom per monomer. In
the case of N1-ZntA also, Cd-Cd interaction was observed. It is possible that the
two cadmium atoms share two thiolate ligands; additionally they may bind to
another S atom and 3 oxygen atoms (Figure 2.9, Table 2.6).
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Figure 2.10 Sequence alignments of the N-terminal domain of PIB ATPases.
N1-ZntA binds to cobalt and copper in addition to lead, cadmium and zinc.
The cobalt and copper structural environment was also examined. Co2+ binds to
3 sulfurs and a oxygen (Figure 2.8), our metal stoichiometry results have shown
that binding of Co2+ to N1-ZntA is sub stoichiometric, suggesting that one Co2+
bridges two protein molecules such that it cannot be displaced by other metal
ions (56). Co2+ ATPases lack the N-terminal domain; this may be because the
CXXC motif is not ideal for Co2+ binding and subsequent transfer to the transport
site in the membrane.
Studies on the Wilson’s disease protein (ATP7B) have shown that not
only is the bound copper in the +1 oxidation state, but also Cu2+ atoms get
reduced to Cu+ upon binding to the domain. Simulations of the copper EXAFS of
for N1-ZntA, with three sulfurs and one copper are best fit with a ligand
environment of 3.0 Cu-S atoms at 2.26 and one Cu-O at 1.98 Å (Figure
2.7,Table2.6), suggesting that Cu+ displays a tetrahedral geometry. The
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cysteine-rich motif in N1-ZntA is not ideal for binding Cu2+, since it is reduced to
Cu+. This may explain why Cu2+-ATPases have a histidine rich motif.
Over the past several years studies of many metalloproteins have all
pointed towards the fact that metal selectivity is not a result of thermodynamic
parameters like binding affinity. Selectivity is achieved through specific coordination geometry which leads to the correct changes in protein conformation.
ZntA is a transporter that has to detoxify E.coli against three different divalent
metal ions of very different sizes. The DCXXC motif is a specialized zinc binding
motif. In order to accommodate the much larger Pb2+ ion, an additional cysteine
from the upstream motif has been conserved. Thus the N-terminal domain of
ZntA has been evolved to bind both lead and zinc efficiently. Unfortunately,
cadmium, which has similar coordination preferences as zinc, but falls in the
middle of the other two in ionic radii, is not bound optimally by N1-ZntA. This
results in Cd2+ being the least efficient substrate for ZntA. The transporter
compensates for the lower activity with Cd2+ by producing more of the protein
when its regulator, ZntR is induced by Cd2+ (26). In conclusion, this study on N1ZntA has shown that Cys31 from the CCCDXXC motif, as well as the GMDCXXC
conserved motif play important roles in metal selectivity to two metal ions of
highly different sizes.
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CHAPTER 3
THE N-TERMINAL DOMAIN OF ZNTA: IT’S ROLE AS AN ATTACHED METAL
CHAPERONE TO THE TRANSPORTER
Evidence is presented in this chapter that the role of the N-terminal domain of
ZntA is to act as a metal chaperone to the core transporter domain.
3.1 Introduction
Inside the cell, several regulatory proteins are in place to control the
intracellular concentration of essential metal ions and as well as toxic metal ions.
An example is metallothionein, which is a metal sequestering protein. It binds to
copper and zinc, serving as a reservoir for these metal ions, and additionally it
also binds to cadmium and helps in the detoxification of this ion (1). In addition to
the metal sequestering proteins, we also have metallochaperones, which bind to
metal ions and transfer them to target proteins. Copper chaperones (Atx1, CopZ,
CCS) (2) are the best studied ones; some other examples of chaperone proteins
are UreE which is a nickel chaperone that delivers Ni2+ to urease (14), frataxin
and human poly(rc) binding protein 1(PCBP1) are iron chaperones that deliver
iron to iron sulfur clusters and ferritin (4). But, so far no

metallochaperone

proteins are known for zinc. Therefore, how do zinc ions exist in organisms? It is
likely that zinc ions are chelated to small molecule chaperones – such as
cysteines, glutathione, citrate, inside the cell, as well as stored in organelles or
bound to storage proteins such as metallothionein.
Zinc is an essential transition metal required for many biological reactions,
but at the same time any increase or decrease in the cellular zinc concentration
can have adverse effects. ZntA is a member of the PIB2 ATPase family which is
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one of the components involved in zinc homeostasis in E.coli (5). ZntA consists
of 8 transmembrane helices and a hydrophilic metal-binding N-terminal region.
For all P-type ATPases, binding of metal ions at the transmembrane
region is a crucial step in the reaction mechanism. How does the transmembrane
region get the metal ion? In the case of Cu+-ATPases, the metal ion is acquired
directly from the cytoplasmic pool by several copper chaperones that deliver the
metal specifically to the Cu+ transporters (6). This metal delivery has been
extensively studied in Cu+-ATPases.
ZntA has two metal binding sites, one in the N-terminal domain and the
other in the membrane domain (7). The N-terminal domain is about ~110
residues long and it has a characteristic CXXC metal binding sequence which is
conserved in many PIB ATPases (CopA, CopB, CadA), Cu+ chaperones like
Atox1, Atx1 and CopZ, metallothioneins, and MerA which is a mercury binding
protein (8, 66). Studies in some of the bacterial Cu+ transporters have shown that
the N-terminal metal binding domain binds to Cu+ with high affinity; the deletion
of this domain does not prevent the activation of the copper transporter but it
does reduce the activity of the transporter (10, 11). Recently it was shown that
Archaeoglobus fulgidus Cu+ chaperone CopZ interacted and delivered Cu+ to
CopA (64). Another enzyme, mercuric ion reductase (MerA), which is involved in
Hg2+ acquisition and reduction in the cytoplasm of bacterial cells, also has the
characteristic CXXC sequence (66). Early studies indicated that the presence of
NmerA is dispensable to the cells; however it was later prove that the N-terminal
domain of NmerA binds to Hg2+ ion and delivers it to the catalytic domain of
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MerA at kinetically efficient rates (66). Studies in our lab have shown that a
mutant lacking the N-terminal domain had 2-3 fold lower activity than the full
length protein, suggesting that the presence of the N-terminus increases the
catalytic activity.
B
A

Figure 3.1. The two metal binding sites in ZntA, one in N-terminal fragment(A)
and the second site in the membrane domain(B).
Both the metal binding domains bind to lead, zinc and cadmium with a
stoichiometry of 1; the binding affinity for the above mentioned metal ions at the
two sites are similar (Pb2+ ~ 109M-1, Zn2+ and Cd2+ ~108M-1) (56, 63). These
results point toward the fact that metal ion exchange between the two sites is
feasible. Since no protein chaperones have been identified for zinc in E.coli, we
wondered if the N-terminal domain acts to acquire zinc ions efficiently from small
molecule chelators in the cytosol and then deliver it to the transmembrane metalbinding site. In the present work, our goal was to investigate the function of the
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N-terminal domain of ZntA (N1-ZntA) as an attached metal chaperone to the
transporter. Our theory is that the N-terminal metal binding domain being solvent
exposed, binds to metal ions more efficiently than the membrane site and then
directly delivers the metal to the transmembrane site. To examine this theory, the
activity of ∆N and ZntA using metal bound N1-ZntA as the substrate was
measured. In the presence of metal bound N1-ZntA everted membrane vesicles
of ∆N-ZntA and ZntA displayed ATP dependent lead, zinc, cadmium
accumulation. Double cysteine mutants in a truncated construct of ZntA (∆46ZntA) labeled with pyrene maleimide displayed excimer formation, indicating that
the two metal binding regions are located in close proximity. The interaction
between N1-ZntA and ∆N was shown by a fluorescence resonance energy
transfer (FRET) experiment where the energy transfer between pyrene
maleimide labeled ∆N-ZntA and coumarin maleimide labeled N1-ZntA was
observed. These studies demonstrate that that the metal-binding site in N1-ZntA
is spatially close to the metal-binding site in the transmembrane region, and it is
feasible for the two sites to exchange metal ions. Thus, we believe that N1-ZntA
performs the role of an attached metal chaperone that binds to metal ions from
small molecule chelators in the cytosol and comes in close proximity of the
membrane domain to facilitate direct metal delivery to the transmembrane site.
3.2 Materials
Plasmid pBAD/mycHis-C and E.coli strain LMG194 were obtained from
Invitrogen; plasmid pET16B was obtained from Novagen. Chemicals for the
ATPase activity assay and standard metal solutions were purchased from
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Sigma. The fluorophores pyrene maleimide, dibromobimane, and coumarine
maleimide were purchased from Molecular Probes. Metal standards used for
inductively coupled plasma mass spectrometry (ICP-MS) were from VWR.
3.3 Methods
3.3.1 Construction of ZntA and ∆N-ZntA with a carboxyl – terminal strep tag
ZntA and ∆N-ZntA were cloned into the expression vector pBAD/MycHisC by polymerase chain reaction (PCR). A Nco1 site was generated at the
initiation codon, and an EcoR1 site was created downstream of the termination
site using the following oligonucleotides, 5’- ATA AGA TTA GCG GAT CCT-3’
and 5’- GCG GAA TTC TTA TTT TTC GAA CTG CGG GTG GCT CCA TCT
CCT GCG CAA C-3’. The PCR product and the vector were digested with Nco1
and EcoR1, after which the amplified DNA fragment and the vector were ligated
together to generate ZntA. The gene for ∆N-ZntA was created with residues 2106 being deleted by PCR, using the oligonucleotide, 5’- CGT GCC ATG GCA
GGC TAT TCC CTG CGC -3’ and the same reverse primer used for making the
ZntA-strep. The resulting PCR product and the vector, following digestion with
Nco1 and EcoR1, were ligated together to create p∆N-ZntA. The sequence of
both ZntA and ∆N-ZntA was confirmed using DNA sequencing analysis; both the
genes were in frame with the strep tag at the carboxyl terminus.
3.3.2 Construction N1-ZntA with carboxyl - terminal strep tag
N1-ZntA(1-111 amino acids) was created by PCR using the plasmid
pZntA as template and the oligonucleotides 5’-CTA CTG TTT CTC CAT ACC C
3’ as forward primer and 5’ GCG CTC GAG TTA TTT TTC GAA CTG CGG GTG
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GCT CCA CAG GGA ATA GCC TGC 3’ as the reverse primer. The amplified
PCR product was cloned into pET16b using Nco1 and Xho1 sites; this was then
transformed into E.coli strains TG1 and Bl21.
3.3.3 Construction of Co-expression vector containing both ∆N–ZntA
(membrane domain) and N1–ZntA (N-terminal domain) in pBADmycHisP
N1-ZntA and ∆N-ZntA were cloned into pBADmycP (commercially
available pBADmycHisC modified with a built in Precision Protease cleavage site
to enable the His tag to be cleaved off) by polymerase chain reaction. The
forward and reverse primers used for ∆N-ZntA were 5’- GCG TGC CAT GGC
AGG CTA TTC 3’ and 5’ GAT CTC GAG TCA TCT CCT GCG CAA CAA 3’
respectively. Then following digestion with Nco1 and Xho1 the PCR product and
pBADmycP were ligated and cloned into E.coli strain TG1. N1–ZntA polymerase
chain reaction was set up using 5’ TAA GAA TTC AGG AGG AAT TAA CCA
TGG CG 3’ as the forward primer and 5’ CCG AAG CTT TCA TTT TTG CAG
CGC AGA 3’ as the reverse primer. The PCR product and pBADmycP were
subjected to double digestion with EcoR1 and HindIII; the fragments were then
ligated and transformed to E.coli strain TG1. Both pBAD-N and pBAD-∆N were
digested with EcoR1 and HindIII, the small fragment from pBAD-N was ligated to
the large fragment of pBAD-∆N digest and then cloned into E.coli strains TG1
and deletion LMG194 (zntA::cat). The sequence was confirmed by DNA
sequencing analysis; both N1-ZntA and ∆N-ZntA were in frame.
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Figure 3.2. Scheme for construction of Co-expression vector.
3.3.4 Construction of double and single cysteine mutants in ∆46-ZntA
∆46-ZntA was chosen instead of ZntA since this fragment of ZntA
contained cysteine residues from the two metal binding sites and the upstream
cysteine 4 residues in the first 45-residue fragment were absent. Thus, ∆46-ZntA
only has five remaining cysteines in total, C59 and C62 from the N-terminal
CXXC motif, C392 and C394 from the transmembrane metal binding site, and
the non-conserved C518. The main purpose of creating these mutations was to
generate proteins with two Cys residues, one in each of the 2 metal binding
sites. C59A/ZntA, C62A/ZntA, C392A/C518A/ZntA and C394A/C518A/ZntA
plasmids were transformed into DAM methylaseƟ strains. Bcl1 digestion of DNA
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is inhibited by the dam gene product of E.coli, which methylates the 6N position
of adenine within the sequence GATC. Therefore Bcl1 digestion of DNA isolated
from E.coli dam cells is inhibited in methylated TG*ATCA and DAM methylaseƔ
strain was used. The plasmids were digested with Bcl1 and EcoR1, the small
fragment from C59A/ZntA and C62A/ZntA were ligated with the large fragment
from C392A/C518/ZntA and C394A/C518A and transformed into E.coli strain
TG1. The sequences were verified by DNA sequencing to check for presence of
triple mutations in ZntA. The plasmids containing the triple mutants were
amplified by PCR using forward primer 5’ TCT GAA CAT ATG TCC GGC ACC
CGC 3’ and reverse primer 5’ GAC GGC GCT ATT CAG ATC CTC 3’, this lead
to the deletion of first 46 residues of ZntA. Following digestion, the PCR product
and pBADmycHisC were ligated and cloned into E.coli strain TG1 and deletion
LMG194 (zntA::cat). The ∆46-ZntA single mutants were created using Quick
change

site

directed

mutagenesis

kit

from

Stratagene.

For

∆46-

C59A/C392A/C394A/C518A/ZntA the forward and reverse primers used were 5’
CTG ATT GGC GCC CCG GCT GCG TTA GTG ATA TCA ACG CCT G 3’ and
5’-CAG GCG TTG ATA TCA CTA ACG CAG CCG GGG CGC CAA TCA G 3’
respectively. The ∆46-C59A/C62A/C392A/C394C/C518A/ZntA was amplified by
PCR using 5’- GTC AGC GGC ATG GAC GCC GCG GCC GCT GCG CGC AAG
GTA G-3’ as the forward primer and 5’-CTA CCT TGC GCG CAG CGG CCG
CGG CGT CCA TGC CGC TGA C-3’ as the reverse primer. The clones were
transformed into E.coli strains TG1 and deletion LMG194 (zntA::cat). All the
genes were in frame with the hexa histidyl tag at the carboxyl terminal end.
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Figure 3.3. The location of restriction enzymes and the position of cysteine
residues that are mutated.
3.3.5 Expression and purification of the N terminal domain of ZntA (N1ZntA)
BL21 (DE3) pLysS cells, transformed with N1-ZntA were grown at 37˚ C
until the O.D600 was 1 and then induced with 0.1mM IPTG. Following induction
the cells were grown for ~4 hours at 30˚ C. Harvested cells were resuspended in
Buffer A (100 mM Tris, pH 8.0, 150 mM NaCl, 1mM EDTA) and stored at -20˚ C
until further use. The frozen cell suspension was thawed and then disrupted at
20,000 p.s.i. The cell lysate was incubated (~20ml) with DNase I (0.02mg/ml)
and 2 mM MgCl2 and then centrifuged at 8000 rpm for 30 min, after which the
supernatant was then centrifuged at 40,000 rpm for 1 h. Following centrifugation
the supernatant was loaded onto a 5ml Strep-Tactin column that was preequilibrated with 2 column volumes of Buffer A. The flow through was collected
and reloaded on the column. After the cell extract completely entered the
column, the column was washed 5 times with 1 column volume of Buffer A. The
protein was eluted with Buffer B (Buffer A + 2.5 mM desthiobiotin, which is a
reversible binding specific competitor). Fractions were collected and analyzed for
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protein. Protein containing fractions were pooled and concentrated using 3K
Amicon cut off concentrators.
3.3.6 Expression and Purification of ZntA and ∆N- ZntA
Both ZntA and ∆N-ZntA were expressed by growing the ZntA and ∆NZntA transformed LMG194 (zntA::cat) cells at 37˚ C in Luria-Bertani medium
supplemented with 100µg/ml ampicillin to mid-log phase and then induced with
0.02% arabinose. Cells were harvested 4 h after induction, washed with ice-cold
buffer containing 25 mM Tris, pH 7 and 100 mM KCl, and stored at -20 ˚C until
further use (50). The entire purification procedure was performed at 4˚C. The
frozen cells were thawed and resuspended in buffer A (25 mM Tris, pH 7.0 with
100 mM sucrose, 1 mM EDTA and 1 mM phenymethylsulfonyl fluoride (PMSF))
at 0.2 g/ml and disrupted at 20,000 p.s.i. The cell lysate was incubated with
DNase I (0.02mg/ml) and 2 mM MgCl2 for 30 min. The cell lysate was then
centrifuged at 8000 rpm for 30 min. The supernatant was centrifuged at 40,000
rpm for 1 h to separate the membrane from the soluble cellular fraction. The
pellet from the ultracentrifugation was resuspended in a low ionic strength buffer
containing 2 mM Tris pH 7.0 with 100 mM sucrose and 1 mM EDTA, 1 mM
PMSF. This removed the F1-ATPase from the membranes, which reduced the
background ATPase activity that was not stimulated by soft metal ions. After the
low ionic strength wash, the membranes were ultracentrifuged once again. The
membranes were stored at 4˚C overnight. The membranes were then
resuspended into Buffer C ( 25 mM Tris, pH 7.0, 100 mM sucrose, 500 mM
NaCl) until O.D280 = 1. Triton-X-100 was added dropwise to a final concentration
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of 1% and the suspension was stirred at 4˚C for 1 h. The suspension was then
centrifuged at 40,000 rpm for 1 h to separate the insoluble membranes. The
Triton-X-100 solublized fraction was then loaded on a strep-tactin column that
was pre-equilibrated with buffer D (buffer C + 0.2% Triton-X-100).The resin was
subsequently washed with 25 ml of Buffer D. The protein was finally eluted with
20 ml of buffer D containing 2.5 mM desthiobiotin. 1 ml fractions were collected
and analyzed for protein. Protein containing fractions were pooled and loaded on
a 40 ml Sephadex G-25 column pre-equilibrated with Buffer E (25 mM Tris pH
7.0, 100 mM sucrose, 50 mM KCl, 0.2% Triton-X-100) to remove the
desthiobiotin. 1 ml fractions were collected and assayed for protein. The protein
containing

fractions

were

pooled

and

concentrated

using

Centricon

concentrators. The concentrated protein was then stored at -70˚C using glycerol
as the cryoprotectant.
3.3.7 Protein concentration determination
Protein concentrations were determined using the bichinchonic acid reagent with
bovine serum albumin as standard.
3.3.8 Metal bound sample preparation for ATPase activity measurements
and transport assays
In assays where the N1-ZntA metal complex was used as the metal
source, N1-ZntA protein was reduced with 1mM TCEP for 1 hour at 4 ˚ C. The
reduced protein was then incubated with metal salts for 1 hour at 4˚ C; the
excess metal was removed by passing through a Sephadex G– 25 column (56).
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3.3.9 Measurement of Metal Concentration by ICP-MS
The metal content was measured by a PE Sciex Elan 9000 ICP-MS
(inductively coupled mass spectrometry) with a cross-flow nebulizer and Scott
type spray chamber. The RF power was 1000 W, and the argon flow was
optimized at 0.92 L/min. The optimum lens voltage was centered on rhodium
sensitivity. The data were collected as counts per second. Lead, Cadmium and
Zinc standards were obtained from VWR. Standard calibration curves were
determined from samples diluted from stock solutions of 1000 ppm standard
solutions. The samples and standards solutions were all diluted in 2% HNO3.
3.3.10 ATPase activity assay
The metal dependant ATPase activity of the purified proteins (ZntA, ∆NZntA) was assayed by the pyruvate kinase and lactate dehydrogenase coupled
spectroscopic assay (50). In this assay, the ATP regeneration from ADP is
coupled to the oxidation of NADH. The reaction was monitored at 340 nm for 20
min. Prior to the assay the purified ZntA/∆N-ZntA was incubated with 2 mM
dithiothrethiol (DTT) at 4˚C for 1 h. The assay buffer was made up of 0.1 M
acetic acid, 0.05 M Bis Tris, and 0.05 M triethanolamine, pH 7.0. The reaction
mixture also contained 0.1% purified asolectin, 0.1% Triton-X-100, 10% glycerol,
5.0 mM each ATP and Mg(II), 0.25 mM NADH, 1.25 mM phosphoenolpyruvate,
14 units of pyruvate kinase, and 20 units of lactate dehydrogenase, with or
without lead, cadmium and zinc ions. To check the metal transfer from the Nterminal region of ZntA (N1-ZntA) to the membrane region of ZntA, metal bound
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N1-ZntA was used as a substrate for measuring the ATPase activity. Data were
fitted to Michaelis-Menten equation.
v = Vmax x S/ (KM + S)
where, Vmax equals the maximum velocity, S is the concentration of metal/N1ZntA bound metal, KM is the Michaelis constant for the substrate.
3.3.11 Transport Assays in everted membrane vesicles
ZntA and ∆N cells were resuspended in Buffer A (25mM Tris, pH 7.0 with
100mM sucrose, 1 mM EDTA and 1mM phenymethylsulfonyl fluoride (PMSF)) at
0.2 g/ml and disrupted at 20,000 p.s.i. The cell lysate was incubated with DNase
I (0.02 mg/ml) and 2 mM MgCl2 for 30 mins. Unbroken cells were removed by
centrifugation at 8000 x g for 30 min. Membrane vesicles were pelleted by
centrifugation at 40,000 x g for 60 min, washed and then resuspended in buffer
containing 25 mM Bis-Tris pH 7.0, 250 mM sucrose and 500 mM NaCl. The
resuspended pellets were frozen in aliquots and stored at -70˚C with glycerol as
the cryoprotectant. The transport assays were performed at room temperature.
The assay mixture contained 900 µl of 25 mM Bis-Tris, pH 7.0, 200 mM KCl, 250
mM sucrose, 1–2 mg of membrane protein, 5 mM ATP or ADP, 10 µM
lead/cadmium/zinc salts or metal bound N1-ZntA. The reaction was initiated by
addition of 5 mM MgSO4. At intervals, 100 µl sample was withdrawn, filtered
through pre-washed and blocked (blocked by washing with 1 ml of buffer
containing 25 mM Bis-Tris, pH 7.0, 200 mM KCl, 250 mM sucrose and 10 mM
MgSO4) 0.22 µm nitrocellulose filters. After the sample was filtered, the filters
were washed with 5 ml of the above buffer and then dried. In order to measure
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the metal content, the filters were completely digested in 300 µl of 70%
concentrated HNO3 at 70˚C for 20 min. The samples were then diluted with
HPLC grade water, and the total metal content was determined by ICP-MS.

Figure 3.4. Transport Assay in everted membrane vesicles.
3.3.12 Fluorescence Studies to monitor intermolecular crosslinking
Energy transfer experiments were performed using N1-ZntA labeled with
coumarin maleimide and ∆N-ZntA labeled with pyrene maleimide. The proteins
were reduced with 1 mM TCEP for 1 hour at 4˚C and then incubated with ~2 fold
excess fluorescent probes. The labeled proteins were then passed through
Sephadex G-25 columns to remove the excess fluorophore. Labeling
stoichiometries for each probe were calculated using the extinction coefficient of
40,000 cm-1 M-1 for pyrene maleimide at 338 nm, and 33,000 cm-1 M-1 for
coumarin maleimide at 384 nm (73). The fluorescence measurements were
performed using a Photon Technology International spectrofluorimeter. Energy
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transfer between ∆N-ZntA bound pyrene maleimide and N1-ZntA bound
coumarin maleimide was followed in this experiment using the pyrene maleimide
excitation wavelength of 340 nm and monitoring its emission in the absence and
presence of labeled N1-ZntA.
3.3.13 Fluorescence studies to monitor intramolecular crosslinking
Single and double cysteine mutants that were purified with 0.05 mM
dodecyl maltoside (DDM) instead of Triton-X-100 were reduced with 1mM TCEP
and then incubated with 100-fold excess pyrene maleimide at room temperature.
The excess pyrene was removed by passage through gel filtration Sephadex G–
25 columns pre-equilibrated with buffer containing 25 mM Tris, pH 7.0, 100 mM
sucrose, 50 mM KCl and 0.05 mM dodecyl maltoside (DDM). Fractions were
checked for protein by performing crude bichinchonic acid assays. The
concentration of protein bound pyrene maleimide in the pooled fractions was
measured using an extinction coefficient of 40,000 cm-1 M-1 at 340 nm.
Fluorescence measurements were performed using Photon Technology
International spectrofluorimeter. The samples were excited at 340 nm, and the
emission spectrum recorded in the range 350-600 nm. Pyrene maleimide shows
emission peaks at 376 nm and 396 nm (74-75). Pyrene also shows a
characteristic excimer emission at ~470 nm when two pyrene molecules are
within 4-6 Å of each other. The formation of this excimer was monitored (75).
3.3.14 Competition Survival Assay
The E.coli strains LMG194 (zntA::cat) transformed with pZntA and p∆N-ZntA
were grown overnight at 37˚C in low-phosphate medium with either ampicillin
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(100 µg/ml) or chloramphenicol (25 µg/ml). The overnight cultures were mixed in
a 1:1 ratio, and diluted 1:100 in fresh low-phosphate medium containing 100 µg
ampicillin and 50 µM zinc chloride, and grown at 37˚C overnight. Each morning,
for 6 consecutive days, the overnight cultures were diluted 1:100 into fresh
media and grown. Plasmids were extracted from the mixed culture, and equal
amounts of DNA were analyzed by digestion with Nco1 and EcoR1. The
digested DNA fragments were run on a 0.7% agarose gel containing 0.5 µg/ml
ethidium bromide and observed at 302 nm.
3.3.15 Sensitivity to metal salts
The sensitivity of E.coli strains LMG194 and LMG194 (zntA::cat) and
LMG194 (zntA::cat) transformed with pZntA, p∆N-ZntA, p∆N-N1 to lead,
cadmium and zinc was measured. The cells were grown in low phosphate
media, pH 7.5. Cells were grown overnight and then diluted 100 fold in the same
media in the presence of lead acetate, zinc chloride, and cadmium chloride. Cell
growth at 37 ˚C was monitored at 600 nm over a period of 24 hours.
3.4 Results
3.4.1 N1-ZntA confers a Competitive Advantage to ZntA
From previous studies in the lab, it was observed that ∆N-ZntA is active in
vivo but it grows more slowly compared to ZntA (56). To understand the
importance of the N-terminal domain of ZntA in providing a survival advantage to
ZntA, a competition survival experiment was performed (76). The E.coli strain
LMG (zntA::cat), in which the ZntA gene had been deleted were used. These
had either a plasmid with ZntA or ∆N-ZntA in the same vector. Equal amounts of
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the two types of cells were mixed together and grown in the presence of 50 µM
zinc in low phosphate medium. Each day the mixed culture was diluted 100 fold,
and the amount of ∆N-ZntA and ZntA plasmids was analyzed by restriction
enzyme digestion with Nco1 and EcoR1. Digestion of both plasmids produced a
4.2 kbp fragment and a 2 kbp fragment for ZntA, and 1.8 kbp fragment for ∆NZntA. After day 3, ∆N-ZntA completely disappeared (Figure 3.5). Thus, the
presence of the N-terminal domain in the ZntA gene allowed it to competitively
survive compared to a transporter lacking this domain.
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ZntA
∆N
Figure 3.5. Molecular competition between ZntA and ∆N-ZntA.
Cells of E.coli strain LMG194(zntA::cat) with either ZntA or ∆N-ZntA were grown
in mixed culture for 9 days with daily dilutions into fresh ZAB medium in the
presence of 50µM Zn. Equal amounts of DNA were separated by electrophoresis
on a 0.7% agarose gel. The plasmids on Nco1 and EcoR1 digestion produced a
4.1-kbp fragment of vector DNA, and a 2 kbp fragment of ZntA and 1.8 kbp
fragment of ∆N. The restriction digestion fragments, of ZntA before growth (Lane
2), ∆N (Lane 3), after day 1 (Lane 4), after day2 (lane 5), after day 3 (lane 6),
after day 4 (lane 7), after day 5 (lane 8), after day 6 (lane 9), after day 7 (lane 8).

3.4.2 The resistance profile of a co-expression vector in the presence of
Pb2+, Cd2+, and Zn2+
With the observation that N1-ZntA provides a survival advantage to ZntA,
we wanted to verify if it also provides a growth advantage when expressed as a
separate domain. We constructed a co-expression plasmid which had both ∆N-
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ZntA and N1-ZntA (∆N.N1). This was then cloned into an E.coli strain from which
the entire zntA gene was deleted. The time courses of growth of wild type E.coli
strain, LMG194, the zntA-deleted strain, LMG194(zntA::cat), and the deleted
strain transformed with plasmids containing either a copy of the wtzntA gene,
∆N, or ∆N.N1 are shown in Figure 3.6. All the strains were able to grow in the
presence of 10µM Pb2+, 50µM Zn2+, and 5µM Cd2+. When compared to the
growth of ZntA, both ∆N-ZntA and ∆N.N1 grew slowly. The profile of ∆N.N1 was
identical to that of ∆N-ZntA with respect to lead, cadmium and zinc. This may be
because the N1-ZntA is not directly attached to ∆N-ZntA and therefore it does
not provide an additional support to ∆N-ZntA for growth.
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Figure 3.6. Resistance to lead, zinc, and cadmium salts by the wild type strains,
LMG194 ( ), LMG194 (zntA::cat) (■), and the zntA deleted strain transformed
with plasmids ZntA (▲), ∆N-ZntA(x), and ∆N.N1 (*). The cells were grown in low
phosphate medium in the presence of 10 µM lead acetate, 50 µM zinc chloride,
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and 5 µM cadmium chloride at 37˚C, and the cell growth was monitored at the
mentioned time points by measuring the absorbance at 600 nm.
3.4.3 ZntA and ∆N-ZntA membrane vesicles supplied with N1-ZntA-bound
metal as the substrate, can catalyze ATP- dependent transport of lead, zinc
and cadmium
In this experiment we tested the ability of ZntA and ∆N-ZntA membrane
vesicles to catalyze ATP dependent metal transport when the metal source was
supplied as N1-ZntA bound form. Everted membrane vesicles were prepared
from cells of ∆N-ZntA and ZntA. The metal source provided was in the form of
metal bound N1-ZntA. In the absence or presence of an energy source (ATP)
and

metal

bound

N1-ZntA

supplied

as

the

substrate,

uptake

of

zinc/lead/cadmium by the everted membrane vesicles of both ZntA and ∆N-ZntA
was observed, only when ATP was present (Figure3.7).
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Figure 3.7. ATP dependent metal uptake by everted membrane vesicles (Refer
to Methods section 3.3.11 for detailed reaction conditions). In the absence of
ATP no metal uptake was observed.
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3.4.4 The transmembrane domain of ZntA and ∆N-ZntA, can catalyze ATP
hydrolysis activity when the substrate is metal bound to the N-terminal
domain
Our hypothesis is that the cytosolic N-terminal domain binds to metal and
transfers it directly to the transmembrane metal binding site. Lead, zinc, and
cadmium stimulate ATP hydrolysis for both ZntA and ∆N-ZntA (50). To assess if
the metal bound N-terminal domain can deliver metal ion to the catalytic pump
and in turn activate the pump, the activity of the transporter was measured using
metal bound N1-ZntA as the substrate. As shown in Figure 3.7, metal bound N1ZntA was a very good substrate for the membrane domain (∆N-ZntA). We
wanted to measure and compare the kinetic parameters of ZntA and ∆N-ZntA
using metal bound N1-ZntA as substrate. Earlier results, comparing the ATPase
activity for ZntA and ∆N-ZntA showed that the activity of ∆N-ZntA was 2-3 fold
lower than ZntA (56). Table 3.1 summarizes the kinetic parameters for ∆N-ZntA
and ZntA for metal stimulated ATPase activity in the presence of 5mM MgCl2
and ATP at pH 7.0 and 37˚C.Interestingly, when metal bound N1-ZntA was used
as substrate, the activity of ∆N-ZntA was higher than when the substrates were
free metal ions in buffer (Table 3.1). Also, the Vmax values were lower for ZntA
than for ∆N-ZntA, a reversal of what is observed when free metal ions are used
in the assay buffer. The lower values may be because ZntA already has an Nterminal domain, and addition of metal bound N1-ZntA as substrate leads to the
two metal binding sites (the transmembrane metal binding site and the cytosolic
metal binding site) competing for the metal ion.
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Table 3.1. Kinetic parameters obtained for ∆N-ZntA and ZntA for Pb2+, Cd2+ and
Zn2+as free species in buffer and in the N1-ZntA bound form.

ZntA

∆N-ZntA
Vmax

app KM

Vmax

app KM

(nmol.mg1.min-

(µM)

(nmol.mg1.min-1)

(µM)

1

)

Pb(II)

320 ± 6

11.6 ± 0.8

560 ± 13

5.6 ± 0.6

N1-ZntAPb(II)

404 ± 11

0.8 ± 0.07

250 ± 8.3

0.3 ± 0.04

Cd(II)

66 ± 3

4.1 ± 0.6

60 ± 3

5.5 ± 1.2

N1-ZntACd(II)

300 ± 7.5

0.25 ±

147 ± 8.6

0.36 ±

0.022

0.064

Zn(II)

81 ± 7

9.3 ± 1.2

250 ± 13

10.3 ± 2

N1-ZntAZn(II)

270 ± 14

0.47 ± 0.06

166 ± 7.2

0.3 ±
0.035
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Figure 3.8. ∆N-ZntA ATPase Activity in the presence of Pb2+ (A) and N1ZntA bound Pb2+ (B).
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Figure 3.9. ZntA ATPase Activity in the presence of Pb2+ (A) and N1-ZntA bound
Pb2+.
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3.4.5 Interaction of N1-ZntA with ∆N-ZntA
Whether a direct interaction between the two metal binding sites in N1ZntA and ∆N-ZntA is feasible or not was examined by an energy transfer
experiment. Both sites contain cysteine residues. Therefore, the cysteines in N1ZntA were labeled with coumarin maleimide and that in ∆N-ZntA was labeled
with pyrene maleimide. Both are cysteine specific reagents and are essentially
non-fluorescent until they react with thiols. Coumarin maleimide has an emission
maximum at 469 nm when excited at 384 nm (73). The absorption maximum for
pyrene is around 340 nm. Its emission maximum is usually a doublet peak at
about 376 and 396 nm. When two pyrene molecules are spatially close, they can
form an excimer, with a broad emission spectrum centered at about 470 nm. In
this experiment, the fluorescence resonance energy transfer between the
coumarin maleimide labeled N1-ZntA and pyrene maleimide labeled ∆N-ZntA
was observed, in which the emission energy from pyrene was transferred to
coumarin. The mixture of coumarin maleimide labeled N1-ZntA and pyrene
labeled ∆N-ZntA was excited at 340 nm (excitation emission peak of pyrene); a
characteristic coumarin emission peak at 470 nm was observed (Figure 3.10).
Therefore, coumarin could be excited by transfer of emission energy from the
pyrene emission spectrum, which overlaps with the coumarin excitation
spectrum. This indicates that the two domains, N1-ZntA and ∆N-ZntA can come
close to each other for this energy transfer to occur.
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Figure 3.10. Fluorescence resonance energy transfer from Pyrene maleimide
labeled ∆N-ZntA (peak at 370 and 390 nm) to coumarin maleimide labeled N1ZntA (peak at ~ 470 nm) using an excitation wavelength of 340 nm.
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3.4.6 Proximity of the two metal binding domains binding sites

Figure 3.11. Model showing cysteine residues in ∆46-ZntA.

As mentioned earlier, ZntA has two metal binding sites; one in the
transmembrane region and the other in the cytosolic N-terminal domain. Both the
metal binding sites have conserved cysteine residues (CPC and CXXC). Since
the results of the ATPase activity assay and transport assay have shown that
metal bound to N1-ZntA can be transferred to the membrane site, our hypothesis
is that the cysteine residues of the two metal-binding sites come close to each
other for metal transfer to occur. To examine the proximity of the cysteine
residues in the two domains we used the property of pyrene to form excimer with
a characteristic fluorescence emission spectrum. We constructed mutants in a
truncated form of ZntA called ∆46-ZntA (the first 46 residues of ZntA were
deleted); this construct was used because the two cysteine containing metal
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binding sites were intact and the four upstream cysteine residues were absent.
This helped in generation of mutants in which either one or two cysteines were
present

in

the

entire

C59A/C62/C392A/C394/ZntA,

protein.

The

double

mutants

were

∆46-C59A/C62/C392/C394A/ZntA,

∆46∆46-

C59/C62A/C392A/C394/ZntA, ∆46-C59/C62A/C392/C394A/ZntA. Single mutants
were created for controls; these were ∆46-C59A/C62/C392A/C394A/C518A/ZntA
and ∆46-C59A/C62A/C392A/C394/C518A/ZntA. Each of these mutant proteins
was labeled with pyrene maleimide at room temperature. The labeling ratios for
each of the double mutants are ~ 2 and each of the single mutants is ~ 1. This
was determined using the known extinction coefficient for pyrene maleimide. The
maximum absorbance peak for these mutants was around ~340 nm. When the
emission spectra for these mutants were measured, the characteristic pyrene
peaks at 375 nm and 390 nm were observed; additionally a small, broad peak
centered at ~ 480 nm was observed for double cysteine mutants. This emission
peak is indicative of a pyrene excimer which is formed only when the two pyrene
molecules interact within a distance of 6-10 Å. As a control, the single cysteine
containing proteins when subjected to similar reaction conditions, did not display
the characteristic pyrene excimer. This control experiment indicates that the
excimer formation is not due to dimerization of the mutant proteins. The excimer
formation indicates that the cysteines in the two metal binding sites in ZntA can
approach within 6-10 Å of each other.

Fluorescence Intensity
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Figure 3.12. Emission spectra of pyrene maleimide labeled ∆46-ZntA cysteine
mutants.
3.5 Discussion
Metal binding to the transmembrane region is an essential part of the
ATPase reaction mechanism. ZntA, a PIB2 type ATPase involved in lead, zinc
and cadmium transport, has a hydrophilic N-terminal domain. This domain has a
conserved CXXC motif that has been shown to bind metal ions, which is
conserved in the copper chaperone proteins like Atx1, Atox1, and CopZ. To date
there has been no evidence of metallochaperones involved in zinc homeostasis
and lead and cadmium detoxification. The aim of this work was to test our theory
that the N-terminal domain acts an attached chaperone to the transporter; the N-
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terminal domain efficiently binds metal ions from the cytosol and then directly
delivers them to the metal binding site in the transmembrane region.
Early studies in the lab have shown that deletion of the entire N-terminal
domain of ZntA does not inactivate the transporter; also its metal specificity is
not affected (56). In vivo results show ∆N–ZntA is able to complement the Pb2+,
Zn2+ and Cd2+ sensitivity of a zntA deleted strain, but the growth rate is slower
than ZntA. To investigate this further, we compared the ability of ZntA and ∆NZntA to confer survival advantage to E.coli in toxic metal concentrations. In a
competition assay, by day 3, only cells with ZntA survived (Figure 3.4), indicating
that presence of the N-terminal domain gave ZntA a competitive advantage for
survival in the presence of zinc. Additionally we also constructed a vector where
both ∆N-ZntA and N1-ZntA were co-expressed. The co-expression vector has a
similar resistance profile (Figure 3.5) to ∆N-ZntA, indicating that the N-terminal
domain needs to be directly attached to the rest of the transporter in vivo, for it to
display any growth advantage in the presence of toxic concentrations of lead,
cadmium and zinc.
In vitro, the activity of truncated protein (∆N-ZntA) is 2-3 fold lower than
that of ZntA (56). ICP measurements on N1-ZntA and ∆N–ZntA have shown that
both sites bind metal ions with a stoichiometry of 1; also the metal affinities for
both the sites are similar. These results suggest that metal ion transfer between
the two domains is feasible. If the N1-ZntA does deliver metal ions directly to the
membrane region, the two metal binding sites in the N-terminal domain and
transmembrane domain must come close to each other and interact for metal
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transfer to occur. To investigate this we used cysteine specific fluorophores.
Coumarin maleimide and pyrene maleimide were used to examine the
interaction between the two domains. N1-ZntA labeled with coumarin maleimide
was added to ∆N-ZntA labeled with pyrene maleimide; this mixture was excited
at 340 nm and showed an emission peak at ~470 which is characteristic of
coumarin maleimide, in addition to the expected pyrene maleimide emission
peak. The coumarin emission peak was observed because the emission energy
from pyrene labeled ∆N-ZntA was transferred to the coumarin labeled N1-ZntA,
indication that the two domains can approach close in our in vitro assays (Figure
3.10). To examine the proximity of the two metal binding sites in the full-length
ZntA, we made double and single cysteine mutations in a truncated form of ZntA
(∆46-ZntA) where the first 46 residues were deleted (Figure 3.11). These
mutants were labeled with pyrene maleimide, a thiol specific fluorophore. When
the labeled mutants were excited at 340 nm, the emission spectra for double
mutants showed a peak at 480 nm which corresponds to characteristic excimer
emission peak for pyrene maleimide (Figure 3.12). This excimer or “excited state
dimmer” is formed due to the interactions between the excited state of one
monomer and the ground state of a second monomer (77). Distance and
orientation are the two reasons that lead to formation of pyrene excimer. The
pyrene excited state monomer must be with 6-10Å to interact with the ground
state monomer and after excitation the monomers must orient themselves in the
correct way or else the fluorescence will be quenched. This is a very useful
method to examine the distance between the two sites. The excimer formation
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observed for the pyrene labeled double cysteine mutants demonstrates that the
two metal binding domains come close to each other and should be able to
facilitate metal transfer.
A major goal of this work was to look at metal transfer by the N-terminal
domain to the membrane region, by metal uptake assays using everted
membrane

vesicles

of

∆N-ZntA

and

ZntA

and

also

ATPase

activity

measurements. In both the experiments the metal substrate provided was metal
bound N1-ZntA. Everted ∆N-ZntA and ZntA membrane vesicles both exhibited
ATP dependent lead, zinc and cadmium accumulation by using metal bound N1ZntA as the metal substrate (Figure 3.7). The everted membrane vesicles have
an orientation opposite to that of intact cells; metal accumulation into the vesicle
is same as extrusion from cells (Figure 3.3). Also, metal loaded N1-ZntA was
used in the ATPase activity assay. Pb2+, Zn2+ and Cd2+ loaded N1-ZntA
stimulated the ATPase activity of the transporter. A comparison of the Vmax and
Km parameters for the ATPase activities of ∆N-ZntA and ZntA in the presence of
metal bound N1-ZntA as the substrate with those in the presence of free metal
ion as substrate shows that the metal bound N1-ZntA stimulated activities of ∆NZntA were higher than free metal stimulated activities of ∆N-ZntA. But in the case
of ZntA the activities in the presence of metal bound N1-ZntA was lower than in
the presence of free metal. This may be because the intact N-terminal domain in
ZntA has to first acquire metal ion from the N1-ZntA and then transfer it to the
metal binding site in the membrane; this extra step slows down the rate. It is
possible that for full-length ZntA, the attached N-terminal domain does not allow
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the N1-ZntA fragment from delivering metal ion directly to the transmembrane
site.
All the experiments shown here point towards the fact that the N-terminal
metal site of ZntA comes within a distance of 6-10 Å of the transmembrane site
to deliver metal ions to the membrane transport site (Figure 3.13). The amino
terminal domain of ZntA is important for survival; it functions as an attached
chaperone to the transporter and thus makes the process of metal binding and
hence, transport, more efficient.

Figure 3.13. Model for Metal delivery to transmembrane metal binding site in
ZntA.
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CHAPTER 4
CHARACTERIZING THE METAL BINDING PROPERTIES OF A TRUNCATED
FORM OF ZNTA THAT IS STRUCTURALLY SIMILAR TO THE PINEAL NIGHT
SPECIFIC ATPASE ENCODED BY A SPLICE VARIANT OF THE WILSON
DISEASE GENE, ATP7B
The work presented in this chapter is preliminary in nature. The
experiments performed involve characterizing a truncated form of ZntA that lacks
the first 4 transmembrane helices.
4.1 Introduction

Figure 4.1.Membrane Topology of PIB and P2/P3 ATPases.
ZntA has two metal binding sites, one in the N-terminal region and the
other in the transmembrane region (63). The transmembrane metal site is
essential for activity of the pump. All PIB ATPase family members have eight
transmembrane helices and a few characteristic conserved charged residues in
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the transmembrane region depending on the specific subgroup. All PIB ATPases
contain a conserved motif (C, S, T) P(C, H) in helix 6 (45). In the PIB-1 subfamily,
which is selective for Cu+, Ag+, and the PIB-2 subfamily, which is selective for
Pb2+, Zn2+ and Cd2+, the motif is conserved as CPC. Previous work in our
laboratory on the conserved motif CPC has demonstrated that the alanine
mutations at each of the two cysteine residues resulted in complete loss in
activity and the proteins were also unable to bind metal ion at the
transmembrane metal binding site, indicating that each of the cysteine residues
are important metal-binding ligands (55).
Sequence alignment of helix 8 for P1B-type ATPases shows the presence
of a strictly conserved aspartate residue in the PIB-2 subfamily, which is not
conserved in any other subgroup of the PIB-ATPases. However this aspartate
residue is strictly conserved in the transmembrane helix 6 of P2 and P3 family of
ATPases, which corresponds to helix 8 in PIB-ATPase (62) (Figure 1). Previous
work from our laboratory has shown that Asp714 in ZntA residue is essential for
the overall activity of the protein and it provides ligands to metal ions in the
transmembrane site (62). Studies on the corresponding conserved Asp residue
in the calcium ATPase, which belongs to the P2A family, has shown that this
residue is essential for activity of the pump. Structural studies on the calcium
ATPase has shown the aspartate residue acts as a bridge to the two Ca2+ ions in
the membrane (40). In other members of the P2 family such as the Na+/K+
ATPase and the H+/K+ pumps mutation of this aspartate residue leads to loss in
activity of the protein (78). In the plasma membrane proton pumps which belong
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to the P3 family of ATPases, the aspartate residue is involved in conformational
change of the transporter during catalysis (62).
Thus, in the ZntA subgroup of P1B-type ATPases, both the CPC motif in
helix 6 and the Asp in helix 8 are part of the metal binding site in the
transmembrane domain; these residues are involved in conferring metal
selectivity to the pump.
The pineal gland is an endocrine organ of the brain that is responsible for
the synthesis and secretion of melatonin mainly at night (79). Experiments to
investigate the pineal circadian rhythms led to the identification of a novel protein
called pineal night-specific ATPase (PINA), a night-specific and pineal/retinaspecific splice variant of the ATP7B gene, defects in which cause Wilsons
disease (80). Wilsons disease is an inherited disorder related to copper
transport; it leads to accumulation of copper in the liver and hence, toxicity (20).
Copper is also accumulated in the brain and is thought to be responsible for
neurological and psychiatric abnormalities in some Wilson disease patients (20).
The gene for Wilsons disease encodes a copper transporting ATPase (ATP7B),
which belongs to the PIB-1 subfamily of PIB ATPases, which are selective for Cu+
and Ag+. From sequence analysis it was observed that PINA is identical to the Cterminal half of ATP7B (79). The 5’ region upstream of the open reading frame of
PINA has a 300 bp sequence which is not found in ATP7B and is pineal specific
(79). Unlike ATP7B, PINA lacks the entire N-terminal domain which contains six
CXXC motifs that are involved in copper binding. Also the first four
transmembrane helices are absent (79). PINA however still retains some
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important elements of P-type ATPases such as the phosphorylation domain, the
ATP binding domain and the conserved CPC motif, which is important in metal
binding in both the PIB-1 and PIB-2 subfamilies. Indirect in vivo studies suggested
that although the N-terminal copper binding region and half the transmembrane
helices are absent, the PINA protein may be able to transport copper in a yeast
system but at a much lower efficiency than the ATP7B (79-80); however no
direct proof exists that the PINA protein is an active transporter. So far, very little
is known about the role of the first four transmembrane helices in PIB ATPases;
helices 3 and 4 correspond to helices 1 and 2 in the Ca2+ ATPase. In the Ca2+
ATPase, helices 1-5 undergo major structural changes on metal binding and
phosphorylation (37). With the discovery of PINA, we wanted to test a similar
truncated form of ZntA that lacked the amino terminal domain and the first four
transmembrane helices, Del231-ZntA, in order to investigate if the loss of
upstream four transmembrane helices would affect the activity and the metal
binding ability of the transporter.
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Figure 4.2.Structure of PINA in comparison with ATP7B. PINA is made up of
3.5kb (PINA5.1) and 4.3(PINA5.2) transcripts that are similar to the C-terminal
portion of ATP7B. The regions conserved in the copper transporters are: Metal:
metal binding domains (CXXC motifs); Td:transduction domain (TGEA);
Ch/Ph:metal binding, CPC motif; phosphorylation domain (DKTGT); ATP:ATPbinding domain (GDGXNDXP) (79).

Figure 4. 3. Structures representing ZntA and the truncated form, Del231-ZntA
4.2 Materials
Plasmid pBAD/mycHis-C and E.coli strain LMG194 were obtained
from Invitrogen; plasmid pET16B was obtained from Novagen. Chemicals for the
ATPase activity assay and standard metal solutions were purchased from
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Sigma. Metal standards used for inductively coupled plasma mass spectrometry
(ICP-MS) were from VWR.
4.3 Methods
4.3.1 Construction of Del231-ZntA with a carboxyl-terminal His tag and
carboxyl terminal strep tag
Del231-ZntA with a 6 His tag was created by PCR using the plasmid ∆NZntA as template and the oligonucleotides 5’-CGT GCC ATG GCG CTG AAA
CC- 3’ as forward primer and 5’-GAA TTC TCT CCT GCG CAA CAA TCT TTA
ACG-3’ as the reverse primer. The PCR product and the vector were digested
with Nco1 and EcoR1, after which the amplified DNA fragment and the vector
were ligated together to generate his tagged Del231-ZntA.
Strep tagged Del 231-ZntA was created by using the plasmid ∆N-ZntA as
template and the primers 5’-CGT GCC ATG GCG CTG AAA CC- 3’ as forward
primer and 5’ GCG CTC GAG TTA TTT TTC GAA CTG CGG GTG GCT CCA
CAG GGA ATA GCC TGC 3’ as the reverse primer. The PCR product and the
vector were digested with Nco1 and EcoR1, after which the amplified DNA
fragment and the vector were ligated together to generate strep tagged Del231ZntA. The sequence of both Del-ZntA with the C-terminal his tag and C-terminal
strep tag were confirmed using DNA sequencing analysis; both the genes were
in frame with the corresponding tags at the carboxyl terminus.
4.3.2 Protein expression of Del231-ZntA (his tag and strep tag)
Both the His-tagged and strep tagged Del231-ZntA were expressed by
growing LMG194 (zntA::cat) transformed with Del231-ZntA at 37˚ C in Luria-
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Bertani medium supplemented with 100 µg/ml ampicillin to mid-log phase and
then induced with 0.02% arabinose. Cells were harvested 4 h after induction,
washed with ice-cold buffer containing 25 mM Tris, pH 7 and 100 mM KCl, and
stored at -20˚C till further use (50).
4.3.3 Protein Purification of Del231-ZntA
Protein purification procedures were all performed at 4˚C. Frozen cells
were thawed and resuspended in buffer A (25 mM Tris, pH 7.0, 100 mM
sucrose, 1 mM PMSF, 1 mM EDTA and 1 mM β-mercaptoethanol (BME)) at
0.2g/ml. The cells were broken at 20,000 p.s.i with a French press, the lysed
cells were then incubated with DNase 1 (0.02mg/ml) and 2mM MgCl2 for 30 min.
The lysed cells were then centrifuged at 8000 rpm for 30 min. The supernatant
was then centrifuged at 40,000 rpm for 1 h to separate the membranes from the
soluble fraction of cells. The pellet from this centrifugation was resuspended in
buffer B (1 mM Tris pH 7.0, 100 mM sucrose, 1 mM EDTA, 1 mM PMSF, and 1
mM BME), stirred for 1 hr at 4˚C, and then centrifuged at 40,000 rpm for 1 h. The
membrane fraction was resuspended in buffer C (25 mM Tris pH 7.0, 100 mM
sucrose, 500 mM NaCl, 1 mM PMSF and 1 mM BME). Triton-X-100 was added
to a final concentration of 1% and the suspension was stirred for 1 h at 4˚C. The
solublized membranes were then centrifuged at 40,000 rpm for 1 h to remove
the insoluble fraction.
2+
For the His tagged protein: The supernatant was then loaded on a charged Ni -

pro-bond column. The column was washed successively with buffer C, buffer C +
50 mM imidazole, buffer C + 100 mM imidazole. Finally the protein was eluted
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using 30 ml of buffer C with 300 mM imidazole. 1ml fractions were collected and
analyzed for protein. Protein containing fractions were pooled and loaded on 40
ml Sephadex G-25 columns to remove imidazole. Protein fractions were
collected and concentrated using YM-100 centricons. The protein was stored at 80˚C with 10 % glycerol as a cryoprotectant.
For the Strep tagged protein: The Triton-X-100 solublized fraction was
loaded on a strep-tactin column that was pre-equilibrated with buffer D (buffer C
+ 0.2% Triton-X-100). The resin was subsequently washed with 25ml of Buffer D.
The protein was finally eluted with 20ml of buffer D containing 2.5 mM
desthiobiotin. 1 ml fractions were collected and analyzed for protein. Protein
containing fractions were pooled and loaded on a 40 ml Sephadex G-25 column
pre-equilibrated with Buffer E (25 mM Tris pH 7.0, 100 mM sucrose, 50 mM KCl,
0.2% Triton-X-100) to remove the desthiobiotin. 1ml fractions were collected and
assayed for protein. The protein containing fractions were pooled and
concentrated using Centricon concentrators. The concentrated protein was then
stored at -70˚C using glycerol as the cryoprotectant.
4.3.4 Determination of Protein Concentration
Protein concentrations were determined by the bichinchonic acid assay,
using bovine serum albumin as standard. This assay is a modified Lowry assay,
where the proteins reduce Cu2+ to Cu+ in a concentration dependent manner.
Bichinchonic acid forms a purple complex with Cu+, which has an absorbance
maximum at 562 nm. This absorbance is proportional to the protein
concentration. BSA is used to generate a standard curve.
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4.3.5 Sensitivity to metal salts
The sensitivity of E.coli strains LMG194, LMG194 (zntA::cat) and LMG194
(zntA::cat) transformed with pZntA or Del231-ZntA, to lead, cadmium and zinc
was measured. The cells were grown in low phosphate media, pH 7.5. Cells
were grown overnight and then diluted 100 fold in the same media in the
presence of lead acetate, zinc chloride, and cadmium chloride. Cell growth at 37
˚C was monitored at 600 nm over a period of 24 hours (56, 69).
4.3.6 ATPase Activity Measurements
The activity of Del231-ZntA was measured by a coupled spectroscopic
assay, involving pyruvate kinase and lactate dehydrogenase. The regeneration
of ATP is coupled to the oxidation of NADH, which is monitored at 340 nm (50).
The buffer for the reaction was 0.05 M Bis tris, 0.1 M acetic acid, and 0.05 M
triethanolamine at pH 7.0. The reaction mixture (1 ml) also contained 0.1%
asolectin, 0.2% Triton–X–100, 10 % glycerol, 5 mM ATP, 0.25 mM NADH, 1.25
mM phosphoenolpyruvate, 7 units of pyruvate kinase, and 10 units of lactate
dehydrogenase, with or without metal ion (Zn2+, Pb2+, Cd2+). The proteins were
reduced by incubation with 2 mM DTT for 1 h prior to the reaction. About 0.5-2
mg/ml protein was used per assay. The reaction mixture was incubated for 5
mins at 37˚C before initiating the reaction with 5 mM MgCl2.
Thiolates in the assay buffer are known to increase the ATPase activity
(50). The activity of the mutant was also investigated in the presence of thiolates.
Along with the other assay ingredients, thiolates were also added. The
concentration of the thiolate form of cysteine required to generate a constant
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metal ion: thiolate ion ratio was calculated using the Henderson-Hasselbach
equation, using a pKa of 8.33 for cysteine and a pH of 7.0. The data obtained
was fit to the Michaelis-Menten equation,
v = Vmax x S/ (KM + S)
where, Vmax equals the maximum velocity, S is the concentration of metal, KM is
the Michaelis constant for the substrate metal ion (50).
4.3.7 Preparation of Metal bound Del231-ZntA
To measure the stoichiometry of metals bound to Del231-ZntA, the
protein was reduced with 1 mM TCEP for 1 h at 4 ˚C. The reduced protein was
then incubated with metal salts for 1 hour at 4 ˚C, and then excess metal was
removed by passing through a Sephadex G–25 column (56).
4.3.8 Measurement of Metal Binding Stoichiometry of Del231-ZntA by ICPMS
The metal content was measured by a PE Sciex Elan 9000 ICP-MS
(inductively coupled mass spectrometry) with a cross-flow nebulizer and Scott
type spray chamber. The RF power was 1000 W, and the argon flow was
optimized at 0.92 L/min. The optimum lens voltage was centered on rhodium
sensitivity. The data were collected as counts per second. Lead, Cadmium and
Zinc standards were obtained from VWR. Standard calibration curves were
determined from samples diluted from stock solutions of 1000 ppm standard
solutions. The samples and standards solutions were all diluted in 2% HNO3.
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4.4 Results
4.4.1 The in vivo resistance activity of Del2310ZntA mutant to Pb2+, Zn2+ and
Cd2+ in the growth medium
The zntA deleted E.coli strain, LMG194 (zntA::cat) is sensitive to toxic
levels of Pb2+, Zn2+ and Cd2+; it is unable to grow even after 24-30 h and this
sensitivity can be complemented by wtzntA. However when this zntA deleted
strain was complemented with the del231-zntA gene, it was unable to confer
resistance to Pb2+, Zn2+ and Cd2+.

Figure 4.4. Resistance to Lead, Zinc and Cadmium salts by the wild type strain
LMG194, the zntA-deleted strain LMG194(zntA::cat), and the deleted strain
transformed with plasmids containing wtzntA and del231-ZntA.The strains were
grown in the presence of varying metal concentrations and the absorbance was
measured after 24 hours.
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Figure 4.4. Resistance to Lead, Zinc and Cadmium salts by the wild type strain
LMG194, the zntA-deleted strain LMG194(zntA::cat), and the deleted strain
transformed with plasmids containing wtzntA and del231-ZntA.The strains were
grown in the presence of varying metal concentrations and the absorbance was
measured after 24 hours.
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4.4.2 Activity of the purified Del231-ZntA
The ATPase activity of Del231-ZntA and ZntA was measured for the metal
ions Pb2+, Zn2+ and Cd2+. Previous studies showed that the metals ions stimulate
the ATP hydrolysis activity of wtZntA, with Pb2+ exhibiting the highest activity
(50). Del231-ZntA did not show any metal induced ATPase activity. There is a 48 fold increase in the ATPase activity of ZntA in the presence of thiolate forms of
cysteine or glutathione in the assay medium (50). The activities for wtzntA and
Del231-ZntA were measured in the presence of metal ions and thiolate form of
cysteine in the ratio 1:1 for Pb2+, Zn2+ and Cd2+. The Del231-ZntA showed
extremely small but measurable activities in the presence of the thiolate form of
cysteine (Table 4.1).
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Table 4.1. Kinetic Parameters obtained for ZntA and Del231-ZntA, in the
presence of the thiolate form of cysteine present at a concentration equal to the
M2+ concentration.
Pb2+ + Thiolate
Vmax

KM

nmoles/mg/min

µM

ZntA

2500 ± 70

166 ± 16

Del231-

15 ± 0.6

109 ± 15

ZntA
2+

Zn

+ Thiolate

Vmax

KM

nmoles/mg/min

µM

ZntA

710 ± 28

96 ± 11

Del231-

5 ± 0.16

45 ± 7.2

ZntA
2+

Cd

+ Thiolate

Vmax

KM

nmoles/mg/min

µM

ZntA

1025 ± 25

252 ± 16

Del231-

2 ± 0.11

53 ± 12

ZntA
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4.4.3 Stoichiometry of Metal Binding to Del231-ZntA using ICP-MS
Del231-ZntA has the conserved metal binding motif (CPC) and the
conserved Asp714 (original ZntA numbering). To investigate if the truncated
protein was able to bind metal ions, we determined the metal binding
stoichiometries of the truncated protein purified with a strep-tag. Wild-type ZntA
can bind to two metal ions with high affinity. ∆N-ZntA which lacks the amino
terminal domain, binds to Pb2+, Zn2+ and Cd2+ with a stoichiometry of 1. It was
observed that Del231-ZntA bound to Pb2+, Zn2+ and Cd2+ with a stoichiometry of
0.5.
Table 4.2. Stoichiometry of Metal bound to N1-ZntA and Del231-ZntA using
Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
Lead

Zinc

Cadmium

ZntA

2 ± 0.0

2 ± 0.1

2 ± 0.0

∆N-ZntA

1 ± 0.1

1 ± 0.0

1 ± 0.0

Del231-ZntA

0.5 ± 0.0

0.5 ± 0.1

0.5 ± 0.0

4.5 Discussion
Most P-type ATPases contain metal binding motifs (CXXC, histidine and
methionine rich motifs) in their amino terminal domains. Transporters in the
Zn2+/Pb2+/Cd2+ and Cu+/Ag+ subgroups all have an N-terminal metal-binding
domain containing 1-6 copies of the CXXC motif. Both these subgroups also
have the CPC motif in TM 6, and a conserved Asp in TM 8 for the Zn2+/Pb2+/Cd2+
subgroup. So far, our investigation showed that these three residues are
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involved in binding the metal ion in the transmembrane domain and conferring
selectivity to the bound metal in ZntA. The function of the first four TM helices in
the P1B-type ATPases is unclear; also it is not known whether they contribute to
metal binding or not. They do not have any conserved residues that are polar. In
order to test whether TMs 5-8 were adequate in metal binding and transport, we
created a truncated form of ZntA which is similar to PINA. In vivo, Del231-ZntA
did not confer resistance to Pb2+, Zn2+and Cd2+; its resistance profile was similar
to the zntA deleted strain, indicating that both the amino terminal and the first
four transmembrane helices are necessary for growth and survival. The
truncated protein did not display any activity in the presence lead, zinc and
cadmium. When the metal thiolate complex was used as the substrate, very low
levels of activity were observed. Given that the in vitro activity of del231-ZntA is
very low compared to ZntA, it is not surprising that in vivo, this truncated mutant
is unable to provide resistance to metal salts.
However, the fact that some activity was observed in vitro, suggested to
us that Del231-ZntA would be able to bind metal ions. Our results show that
Del231-ZntA was indeed able to bind lead, zinc and cadmium, but surprisingly,
with a stoichiometry of 0.5, unlike ∆N-ZntA, which binds metal ions with a
stoichiometry of 1. This result shows that TMs 5-8 are able to bind metal ions
without the presence of TMs 1-4. It is possible that TMs 1-4 provide a fourth
metal binding ligand, which when absent, forces the transporter to dimerize, with
a second monomer providing the fourth ligand, leading to a stoichiometry of 0.5.
It is also possible that TMs 1-4 do not provide a metal-binding ligand, but in their
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absence, the transmembrane region folds in such a way that the transporter is
able to dimerize easily in the membrane region, and therefore accommodates
only one metal ion per dimer, again resulting in a stoichiometry of 0.5. Further
studies are needed to show whether the CPC motif as well as Asp714 are all
metal ligands in Del231-ZntA, and whether the metal binding affinity in Del231ZntA is similar to that of ZntA or ∆N-ZntA. It is clear though, that the first four
transmembrane helices of ZntA are necessary for high activity of the transporter,
and hence, growth in vivo in the presence of toxic concentrations of Pb2+, Zn2+
and Cd2+. This suggests that the PINA protein may not be a good Cu+
transporter, but may be able to bind and transfer Cu+ to other Cu+-binding
proteins, especially membrane-bound Cu+-binding proteins.
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS
The major aims of this thesis have been to study the structural, and
biochemical aspects of ZntA which has given us an insight into the different
mechanisms adopted by metal transporting proteins to achieve metal selectivity.
I have been able to answer some of the many questions by characterizing the
conserved cysteine residues (CCCDXXC and GMDCXXC) in the cytoplasmic Nterminal domain of ZntA and the interaction of this domain with the core
transporter. This work is presented in Chapters 2 and 3. We began by altering
the individual cysteine residues to alanines and the individual aspartate residues
to alanine and asparagine. These mutants were fully characterized for in vivo
resistance, ATPase activity, lead, zinc and cadmium binding (Fluorescence
spectroscopy, ICP-MS) and the lead, zinc, cadmium binding site structures were
examined by XAS. Our results suggested that Cys31 from the CCCDXXC motif,
as well as the GMDCXXC conserved motif play important roles in metal
selectivity to metal ions of highly different sizes.
Research presented in Chapter 3 sheds light on the role of the N-terminal
domain as an attached chaperone to the core transport domain. The interaction
between the two domains has been characterized using vivo assays, FRET
studies; ATPase activity measurements. From the results obtained we can
conclude that the amino terminal domain of ZntA is important for survival and it
efficiently transports metal ion to the membrane domain.

153
In ongoing studies, solving the structure of the Pb2+-bound N-terminal
domain will give us detailed structural information about the positions of the two
cysteine-rich motifs in this domain. So far there is no available structural data
with regards to the metal binding site in the transmembrane domain of ZntA; Xray absorption studies on the metal bound form of ∆N-ZntA will provide us an
insight into ligand environment and geometry. Within the cell, other than
metalloproteins, there are several small-molecule chelating agents; we have
studied the effect of two such agents (glutathione and cysteine) on the ATPase
activity of ZntA. The metal:thiolate complex increases the activity of the
transporter 4-5 fold. Another aspect to study would be to look at the effect of
different chelating agents (citrate, histidine, imidazole etc) on the activity of the
transporter in order to learn if metal complexes of sulfur-containing chelators
behave differently from those of oxygen or nitrogen-containing chelators with
respect to being efficient substrates of ZntA..
The fourth chapter presented in the thesis is work in progress. The role of
the first four transmembrane helices in PIB-ATPases is not known. In P2 and P3
ATPases, the helices 1 to 5 undergo important conformational changes on metal
binding. Loss of these helices in ZntA leads to very low activity of the pump and
also the metal binding stoichiometry is reduced to 0.5. Further studies such as
determining the Pb2+, Cd2+ and Zn2+ binding affinities for Del231-ZntA by
competition titration experiments and determining the metal binding ligands in
this mutant, will provide details regarding the role of these helices. Our results
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may be able to provide an indication about the biological function of PINA, the
splice variant of the Wilson Cu+-ATPase.
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ZntA from Escherichia coli is a member of the P1B-type ATPase family of
transporters. The P1B-type ATPase pumps maintain cellular homeostasis of
heavy metals such as Zn2+, Co2+, Cu2+, Cu+, and mediate resistance to toxic
metals such as Pb2+, Cd2+ and Ag+. ZntA confers resistance to Pb2+, Cd2+ and
Zn2+ by pumping these ions out of the cytoplasm. ZntA has two metal binding
sites, one in the hydrophilic N-terminal domain and the other in the
transmembrane region. The cysteine-rich N-terminal domain has ~110 amino
acids and the conserved motifs –CCCDXXC- and –DCXXC-. The role of these
motifs in metal-binding specificity was determined by site-specific mutagenesis,
metal-binding studies, functional assays and EXAFS. Our results show that both
motifs play a role in metal binding and conferring the broad metal selectivity
shown by ZntA.
The N-terminal domain and the N-terminal metal-binding site are not
essential for activity, but increase the kinetics of the pump and therefore, confer
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a survival advantage to the organism. The transmembrane metal-binding site is
essential for functioning of the pump. We investigated the role of the N-terminal
metal-binding site in the overall function of the pump, and any possible
interactions with the transmembrane site. Our results show that the isolated Nterminal domain is capable of transferring its bound metal ion to both wtZntA and
to a ZntA mutant lacking the N-terminal domain. Activities obtained with the
metal ion bound to the N-terminal domain are much higher than when the metal
ion is present as low-affinity complexes in the assay buffer. Together with metal
binding affinities of the two sites, these data show that the N-terminal metal site
is capable of transferring metal ions directly to the transmembrane metal site.
Thus the N-terminal domain acts as a metal chaperone to the transport site in
this class of pumps. The function of this “attached” chaperone appears to be to
increase the rate of metal binding to the transmembrane site and thus increase
the overall kinetics of the pump.
In the last chapter, our studies on a truncated form of ZntA (Del231-ZntA),
which lacks the first four transmembrane helices, are presented. This truncated
form was based on the natural PINA splice variant of the copper-transporting
Wilson disease-associated protein. Del231-ZntA had very low in vitro activity but
was able to bind metal ions with a stoichiometry of 0.5, instead of the expected
1.
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